<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>000309</Identifier>
    <IdentifierDoi>10.3205/000309</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-0003096</IdentifierUrn>
    <ArticleType>Review Article</ArticleType>
    <TitleGroup>
      <Title language="en">Internal limiting membrane peeling in macular hole surgery</Title>
      <TitleTranslated language="de">Internal Limiting Membrane Peeling in der Makulaforamen-Operation</TitleTranslated>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Pradhan</Lastname>
          <LastnameHeading>Pradhan</LastnameHeading>
          <Firstname>Deepti</Firstname>
          <Initials>D</Initials>
        </PersonNames>
        <Address>Kirtipur Eye Hospital, Department of Vitreoretinal Services, Tahalcha, Tinkune, 44618 Kirtipur-10, Nepal, Phone: &#43;977 9808119112<Affiliation>Kirtipur Eye Hospital, Department of Vitreoretinal Services, Kirtipur, Nepal</Affiliation></Address>
        <Email>deeptiprdhn&#64;gmail.com</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Agarwal</Lastname>
          <LastnameHeading>Agarwal</LastnameHeading>
          <Firstname>Lalit</Firstname>
          <Initials>L</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Biratnagar Eye Hospital, Department of Vitreoretinal Services, Biratnagar, Nepal</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Joshi</Lastname>
          <LastnameHeading>Joshi</LastnameHeading>
          <Firstname>Ichhya</Firstname>
          <Initials>I</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Biratnagar Eye Hospital, Department of Vitreoretinal Services, Biratnagar, Nepal</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Kushwaha</Lastname>
          <LastnameHeading>Kushwaha</LastnameHeading>
          <Firstname>Anamika</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Biratnagar Eye Hospital, Department of Vitreoretinal Services, Biratnagar, Nepal</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Aditya</Lastname>
          <LastnameHeading>Aditya</LastnameHeading>
          <Firstname>Kshitij</Firstname>
          <Initials>K</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Chandra Eye Care, Varanasi, India</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Kumari</Lastname>
          <LastnameHeading>Kumari</LastnameHeading>
          <Firstname>Archana</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Prasad Eye Hospital, Ramgarh, Jharkhand, India</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">adverse effects of ILM peeling</Keyword>
      <Keyword language="en">vital dye staining</Keyword>
      <Keyword language="en">temporal ILM flap</Keyword>
      <Keyword language="en">DONFL</Keyword>
      <Keyword language="en">Ocriplasmin</Keyword>
      <Keyword language="de">unerw&#252;nschte Wirkungen des ILM-Peelings</Keyword>
      <Keyword language="de">Vitalfarbstofff&#228;rbung</Keyword>
      <Keyword language="de">tempor&#228;rer ILM Flap</Keyword>
      <Keyword language="de">DONFL</Keyword>
      <Keyword language="de">Ocriplasmin</Keyword>
      <SectionHeading language="en">Ophthalmology</SectionHeading>
    </SubjectGroup>
    <DateReceived>20210430</DateReceived>
    <DateRevised>20210923</DateRevised>
    <DatePublishedList>
      
    <DatePublished>20220602</DatePublished></DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>1612-3174</ISSN>
        <Volume>20</Volume>
        <JournalTitle>GMS German Medical Science</JournalTitle>
        <JournalTitleAbbr>GMS Ger Med Sci</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>07</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="de" linked="yes"><Pgraph>Seit der &#196;ra, in der das Makulaforamen als unbehandelbar galt, hat die Makulaforamenchirurgie einen weiten Weg zur&#252;ckgelegt und ist heute eine der erfolgreichsten Operationen. Das Peeling der Internal Limiting Membrane (ILM) ist ein wesentlicher Schritt der Makulaforamenchirurgie, seit die Rolle der ILM in der &#196;tiopathogenese und Progression des Makulaforamens bekannt ist. Jedoch brachte die neue Technik nicht nur Vorteile, sondern auch einige Nachteile, die nicht sofort ersichtlich waren. Mit dem Aufkommen der optischen Spektraldom&#228;nen-Koh&#228;renztomographie wurden die kurz- und langfristigen Auswirkungen des ILM-Peelings auf die Makulastrukturen bekannt, und mit der Mikroperimetrie konnte die Auswirkung auf die Funktion der Makula bewertet werden. Die Technik hat sich im Laufe der Zeit vom totalen Peeling &#252;ber den invertierten Flap bis hin zum nur tempor&#228;ren Peeling und dem tempor&#228;ren Flap weiterentwickelt, um die negativen Auswirkungen zu mildern und das chirurgische Ergebnis zu verbessern. Die ILM-Abrasionstechnik und Ocriplasmin k&#246;nnen in bestimmten F&#228;llen ein ILM-Peeling &#252;berfl&#252;ssig machen, sie haben aber ihre eigenen Einschr&#228;nkungen. Wir diskutieren hier die Rolle der ILM in der Pathogenese des Makulaforamens, die Vorteile und unerw&#252;nschten Wirkungen des ILM-Peelings sowie die verschiedenen Modifikationen des Verfahrens, um anschlie&#223;end die Alternativen zu untersuchen.</Pgraph></Abstract>
    <Abstract language="en" linked="yes"><Pgraph>Since the era when macular hole was considered untreatable, macular hole surgery has come a long way to being one of the most successful surgeries. Internal limiting membrane (ILM) peeling has been an essential step of macular hole surgery since the establishment of the role of ILM in the aetiopathogenesis and progression of macular hole. However, the novel technique was not all virtuous. It had some vices which were not evident immediately. With the advent of spectral domain optical coherence tomography, short- and long-term effects of ILM peeling on macular structures were known; and with microperimetry, its effect on the function of macula could be evaluated. The technique has evolved with time from total peeling to inverted flap to just temporal peeling and temporal flap in an attempt to mitigate its adverse effects and to improve its surgical outcome. ILM abrasion technique and Ocriplasmin may eliminate the need of ILM peeling in selected cases, but they have their own limitations.  We here discuss the role of ILM in the pathogenesis of macular hole, the benefits and adverse effects of ILM peeling, and the various modifications of the procedure, to then explore the alternatives.</Pgraph></Abstract>
    <TextBlock linked="yes" name="1 Introduction">
      <MainHeadline>1 Introduction</MainHeadline><Pgraph>Macular hole (MH) is a full thickness defect in the fovea. Various theories have been proposed regarding its genesis since it was first described by Herman Knapp in 1869 <TextLink reference="1"></TextLink>. The cystic degeneration theory stated that intraretinal cystic changes occur, which coalesce to form a full-thickness MH <TextLink reference="2"></TextLink>. Aging and other changes in retinal vasculature were believed to cause cystic degeneration leading to the formation of a MH <TextLink reference="3"></TextLink>. The role of anteroposterior vitreous traction force has long been suspected &#8211; and later supported by biomicroscopic examinations &#8211; to play an important role in the genesis of a MH <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>. In 1988, Gass postulated that contraction of the premacular vitreous cortex and tangential vitreous traction cause detachment of central photoreceptors and subsequent MH <TextLink reference="7"></TextLink>. The events transpiring at the vitreoretinal interface before the formation of MH or during early stages of MH were better known with the dawn of the era of optical coherence tomography (OCT) when it was possible to visualize partially detached posterior vitreous with persistent attachment at the disc, the vascular arcades and the foveal center <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink>.</Pgraph><Pgraph>The internal limiting membrane (ILM) is made of internal expansion of M&#252;ller cell footplates and a basement membrane which is composed of collagen fibers, glycosaminoglycans, laminin and fibronectin connected to peripheral fibers of the cortical vitreous <TextLink reference="10"></TextLink>. ILM is thick over the macula and thin at the peripheral retina. The basement membrane layer of ILM is thin over the fovea, the optic nerve head and the major vascular arcades, where vitreous fibers are directly and strongly attached to the retina. The M&#252;ller stratum thickens into a conical shape at the foveal center connecting ILM to the external limiting membrane, which is called the M&#252;ller cap. With the liquefaction of vitreous, a precortical pocket of liquified vitreous is formed. This gradually seeps through the optic disc separating cortical vitreous from the posterior pole. However, in the eyes predisposed to MH, there is anomalous vitreofoveal adhesion which causes anteroposterior traction leading to avulsion of the M&#252;ller cap. Further expansion of the hole occurs due to tangential traction, caused by shortening of the edges of ILM and proliferation of glial and M&#252;ller cells over the ILM <TextLink reference="11"></TextLink>.</Pgraph><Pgraph>The staging of MH depicting its evolution was first proposed by Gass in 1988 on the basis of biomicroscopic examination. Stage 1a was foveolar detachment, which on clinical examination appeared as decreased or loss of foveal depression and appearance of yellow spot of 100&#8211;200 &#181; diameter due to the presence of xanthophylls in the receptors. Stage 1b was marked by foveal detachment with centrifugal displacement of the foveolar retina, bridged on top by contracted prefoveolar cortical vitreous, resulting in appearance of a yellow ring of 200&#8211;350 &#181; in diameter. When this progressed to full thickness macular hole of &#8804;400 &#181; central or eccentric, it was termed as stage 2 MH. As the hole enlarged further, accompanied by vitreofoveal separation with or without formation of a prefoveolar opacity, it qualified as stage 3 MH. Stage 4 was reached when vitreopapillary separation occurred, forming a Weiss ring <TextLink reference="7"></TextLink>, <TextLink reference="12"></TextLink>.</Pgraph><Pgraph>The international study group has classified vitreoretinal interface diseases into three groups: vitreomacular adhesion (VMA), vitreomacular traction (VMT) and full thickness MH. VMA does not cause any change in the foveal anatomy and hence does not interfere with vision. VMT causes distortion of the foveal contour with intraretinal changes. Both VMA and VMT are divided further, on the basis of dimension of attachment, into focal (&#60;1500 &#181;) or broad (&#62;1500 &#181;). MH is categorized on the basis of size as small (&#60;250 &#181;), medium (250&#8211;400 &#181;) and large (&#62;400 &#181;); on the basis of presence or absence of VMT and on the basis of etiology as primary or secondary <TextLink reference="13"></TextLink>.</Pgraph><Pgraph>Macular microhole (MMH) is a full thickness defect of &#60;150 &#181; size at the fovea; and a partial thickness defect of the same size in the outer retina is a foveal red spot (FRS). Both are caused by vitreofoveal traction (VFT), associated either with evolution of posterior vitreous detachment (PVD) or with trauma. Patients complain of central scotoma or diminution of vision of sudden onset. FRS may also result from closure of MH or MMH. Both of them have a better prognosis than stage I and stage II MH as they heal spontaneously with the release of VFT, while 40&#37; of stage 1 and &#62;75&#37; of stage 2 holes progress to further stages <TextLink reference="14"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="2 The inception of the MH surgery">
      <MainHeadline>2 The inception of the MH surgery</MainHeadline><Pgraph>MH was considered an inoperable condition and patients were counseled accordingly. It was Kelly who first had the idea of flattening the edges of MH with vitrectomy and gas, which he thought might improve the vision. In September 1985, he first performed the surgery but was unsuccessful as he was unaware of posterior cortical vitreous, which when later detached caused bullous retinal detachment <TextLink reference="15"></TextLink>.</Pgraph><Pgraph>Kelly together with Wendel continued doing more surgeries and learnt techniques to identify residual cortical vitreous. The silicon tip of the extrusion needle, when swept across the retina under active aspiration, flexed if it engaged the vitreous. This was termed &#8220;fish strike sign&#8221;. Kelly and Wendel also noticed that on proceeding with fluid air exchange, residual vitreous if present appeared as viscous substance on the retinal surface towards the end of fluid aspiration. They published their first report on MH surgery in 1991 and described a 5-step procedure: vitrectomy, removal of cortical vitreous, stripping of the epiretinal membrane (ERM) if any, complete fluid-gas (SF<Subscript>6</Subscript>) exchange and one week of strict prone positioning <TextLink reference="16"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="3 Surgical methods">
      <MainHeadline>3 Surgical methods</MainHeadline><Pgraph>Kelly and Wendel described the membrane as typically friable and difficult to remove, which in retrospect was believed to be ILM. They used a barbed 20- or 22-gauge needle, tissue forceps and a tapered extrusion needle to remove them <TextLink reference="16"></TextLink>. Eckardt et al. in 1997 described ILM peeling (ILMP) as a technique to improve surgical outcome of MH <TextLink reference="17"></TextLink>. They used specially designed forceps to cause &#8220;rhexis&#8221; of ILM of about 3&#8211;4 disc diameter size. With the introduction of vital dyes to stain ILM, the visualization of ILM has improved greatly. A barbed MVR blade or membrane micropick can be used to cause a linear scratch over ILM. Michels membrane pick is then used to lift ILM by horizontal, lamellar dissection, later to be removed by forceps <TextLink reference="15"></TextLink>. Another method is the use of the end of a gripping forceps to pinch and tear a flap of ILM, which is then grasped and peeled off in a circular fashion, creating &#8220;maculorrhexis&#8221; <TextLink reference="18"></TextLink>. A technique described by Morris and Witherspoon involves injecting Healon beneath ILM, ballooning it up, which makes it easier for the surgeon to grab and peel it <TextLink reference="19"></TextLink>.</Pgraph><Pgraph>The introduction of the concept of chromovitrectomy facilitated the procedure of ILM peeling as it helped in the visualization of otherwise transparent ILM. Indocyanine green (ICG) was the first dye used to stain ILM, but there were many contradicting reports, some citing a better outcome with its use, and some reporting about its side effects and worse outcomes. Several other options were then sought out, like infracyanine green (IfCG), Triamcinolone acetate (TA), trypan blue (TB), patent blue and brilliant blue (BB). ICG, IfCG and BB stain ILM better, while TB and PB are preferred for ERM. TA is the best stain for the visualization of vitreous. Among these, BB is considered the best and the safest stain for ILM <TextLink reference="20"></TextLink>, <TextLink reference="21"></TextLink>.</Pgraph><Pgraph>There has been a debate about the appropriate extent of the ILMP. Bae et al. studied the anatomical and visual outcome when the ILM was peeled with the radius of 0.75 disc diameter or 1.5 disc diameter. They concluded that a larger extent of ILMP during MH surgery results in a better outcome, so far as the improvement in metamorphopsia and alleviating the asymmetrical elongation of the foveal tissue are concerned <TextLink reference="22"></TextLink>. Goker et al. suggested that the ILM should be peeled as close to the vascular arcades as possible, as they have shown in their study that a larger area of ILM peeling results in a better anatomical outcome <TextLink reference="23"></TextLink>. A larger area of ILM peeling (4DD) results in a better outcome; nevertheless, in cases with a macular hole closure index &#62;0.5, peeling of 2DD is enough to reach a comparable outcome <TextLink reference="24"></TextLink>.</Pgraph><Pgraph>Although ILMP is accepted as a standard procedure for MH surgery, it has seen several modifications with the aim to achieve a better outcome in more challenging cases, such as long-standing large MH and highly myopic eyes. The inverted ILM flap technique was introduced by Michalewska et al. for large MH, in which ILM is not peeled completely and is left attached at the margins of the MH. This is then inverted over the MH. A closure rate of 98&#37; was achieved with this method <TextLink reference="25"></TextLink>. Further studies and observations showed that higher closure rates and improved visual outcomes could be achieved in refractory, traumatic and highly myopic MH <TextLink reference="26"></TextLink>. The mechanism of hole closure by this method is not clear, but it has been known that ILM placed over the hole contains M&#252;ller cell fragments which can induce gliosis. Kase et al. suggested that glial cells placed on the hole may produce intermediate filaments and provoke tissue remodeling within the MH <TextLink reference="27"></TextLink>.</Pgraph><Pgraph>Shin et al. modified the inverted ILM flap technique such that single-layered ILM covered the MH, providing more physiological and regular structure for glial cells to proliferate. They fashioned a superior ILM flap of one disc diameter, peeled the rest of the ILM around the MH, reflected the flap onto the MH, and injected perfluoro-n-octane (PFO) to keep the flap in place during fluid air exchange. With this technique, one day of post-operative face-down positioning and air tamponade were sufficient for hole closure with a more normal configuration of the fovea without folded membrane and a shorter visual recovery time <TextLink reference="28"></TextLink>, <TextLink reference="29"></TextLink>. Viscoat has been used as an adhesive and ballast to stabilize the ILM flap during fluid air exchange and to minimize the toxic effect of ICG to retinal pigment epithelium (RPE) in large MH in highly myopic eyes <TextLink reference="30"></TextLink>. Similarly, autologous blood clot was used to stabilize and seal the ILM flap <TextLink reference="31"></TextLink>. Chen described a technique of large superior semicircular inverted flap with improved outcome without the need of any stabilizing substance nor of prolonged face-down positioning in MH with high myopia <TextLink reference="32"></TextLink>. A novel technique of donut-shaped ILM peeling in stage 2 MH, preserving central 400 &#956;, thus preventing inner retinal damage, better restoration of foveal structure, and better visual outcome was described by Ho et al. <TextLink reference="33"></TextLink>. Autologous transplantations of free flaps of ILM to cover holes in refractory MH have been shown to improve anatomic and visual outcomes <TextLink reference="34"></TextLink>. Yet another novel technique has been described for large, chronic, full-thickness MH, in which multiple ILM flaps were inverted over each other and the hole-like cabbage leaves <TextLink reference="35"></TextLink>. Chen and Yang used an anterior or posterior capsular flap to plug refractory MH <TextLink reference="36"></TextLink>, while Grewal and Mahmoud introduced the use of an autologous neurosensory retina (NSR) flap as scaffold and plug for refractory myopic MH <TextLink reference="37"></TextLink>. For persistent, chronic and large MH following PPV and ILMP, a silicon soft tip extrusion cannula was used to actively reflux water into the MH, causing &#8220;hydrodissection&#8221; of the MH edges from RPE adhesions if any. This moved the edges further apart, which were then brought closer by brushing them with a soft-tip cannula under passive extrusion. 87.2&#37; of them had a complete anatomical closure and all of them had type 1 closure <TextLink reference="38"></TextLink>. Mohammed et al. punctured NSR at 3 sites: 2DD above, below, and at the temporal edge of the MH, and injected balanced salt solution (BSS) using a 41G subretinal cannula to cause macular detachment <TextLink reference="39"></TextLink>. They used DDMS to massage detached NSR towards the center, avoiding the papillomacular bundle, and finally pinched the temporal edges with end-gripping forceps so that the edges were stretched and came closer. They reported 4 cases of recurrent MH treated with this technique and achieved type 1 closure in all of them <TextLink reference="39"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="4 Surgical outcome">
      <MainHeadline>4 Surgical outcome</MainHeadline><Pgraph>Kelly and Wendel <TextLink reference="16"></TextLink> reported that anatomical success was achieved in 58&#37; of the cases, and improvement in visual acuity by two or more lines was seen in 73&#37; of them. Since then, many papers have been published on MH surgery.</Pgraph><Pgraph>In two large randomized controlled trials (RCTs) <TextLink reference="40"></TextLink>, <TextLink reference="41"></TextLink>, closure was achieved in 69&#37; and 80.6&#37; respectively after vitrectomy, and in 4&#37; and 11.5&#37; following observation. Vision was significantly better after vitrectomy. The former study <TextLink reference="40"></TextLink> included stage 3 and 4 MH, while the latter <TextLink reference="41"></TextLink> studied stage 2 to 4 MH. ILMP, however, was not done in either of these studies <TextLink reference="40"></TextLink>, <TextLink reference="41"></TextLink>.</Pgraph><Pgraph>Eckardt et al. <TextLink reference="17"></TextLink>, employing ILMP in their surgical technique, demonstrated complete closure in 36 of 39 eyes (92&#37;) and visual improvement of two lines in 77&#37; of them. In a large retrospective comparative clinical study <TextLink reference="42"></TextLink>, 100&#37; closure was seen in MH of less than 6 months&#8217; duration treated with ILMP versus 82&#37; in eyes treated with vitrectomy alone. Furthermore, reopening of the MH occurred in 25&#37; of the cases in the latter group. In another group of patients with MH of more than 6 months&#8217; duration treated with ILMP, MH closed in 97&#37; and vision improved by 2 or more Snellen lines in 65&#37; <TextLink reference="42"></TextLink>. A prospective case series <TextLink reference="43"></TextLink> reported successful closure of MH in 96&#37; of the cases, and improvement in vision by at least 2 lines in 85&#37; and by 3 lines in 76&#37;. A clinical study <TextLink reference="44"></TextLink> compared anatomical and visual outcome between two groups of cases following ILMP versus without ILMP. The result was in favor of ILMP with 90&#37; anatomical closure versus only 50&#37; in cases treated without ILMP, and significant visual acuity improvement in 62&#37; and 44&#37;, respectively <TextLink reference="44"></TextLink>. Another study also supported this result <TextLink reference="45"></TextLink>, in which 97 patients in the vitrectomy-only group were compared with 79 patients in the PPV and ILMP with or without ICG staining group. A closure rate of 77.3&#37; and 97&#37;, and a visual gain in 65&#37; and 77.3&#37; was seen in the two groups respectively <TextLink reference="45"></TextLink>. In a prospective non-randomized case series, Haritoglou et al. <TextLink reference="46"></TextLink> followed up patients for at least 12 months. 99 eyes with MH were taken up for PPV with ILMP without the use of any dye. The primary closure rate was 87&#37;. Functional improvement was seen in 97&#37; with a median BCVA of 20&#47;40 and a median gain of 5 lines <TextLink reference="46"></TextLink>.</Pgraph><Pgraph>In an RCT conducted in the Chinese population <TextLink reference="47"></TextLink>, a comparison was made between ICG-assisted ILMP performed in 26 eyes, and vitrectomy-only in 25 eyes. ILMP was found to be superior with an anatomical success rate of 92.3&#37; and improvement in BCVA by 2 or more lines in 84.6&#37;, in contrast to 32&#37; of macular hole closure and 36&#37; of gain in BCVA in the non-ILMP group. The improvement of BCVA in the ILMP group (3.7 lines) was significantly higher than that in the other group (1.5 lines) <TextLink reference="47"></TextLink>.</Pgraph><Pgraph>Christensen et al. <TextLink reference="48"></TextLink> conducted an RCT in which 78 eyes of 75 patients with stage 2 and 3 MH without epiretinal fibrosis of &#8804;12 months duration were randomized into 3 groups: as 25 in vitrectomy only, 34 in vitrectomy with 0.05&#37; ICG-assisted ILMP, and 18 in the 0.15&#37; trypan blue (TB)-assisted ILMP group. Primary closure occurred in 55&#37; of the eyes with stage 2 holes and in 36&#37; of the eyes with stage 3 holes in the vitrectomy-only group, while the rate soared up as high as to 100&#37; in stage 2 holes and 89&#8211;91&#37; in stage 3 holes in the ILMP group. The closure rate was not significantly different between the ICG and TB group (91&#37; vs. 89&#37;). The functional outcome in eyes with primary closure was not significantly different among the 3 groups <TextLink reference="48"></TextLink>.</Pgraph><Pgraph>Tadayoni <TextLink reference="49"></TextLink>, in a multicentric RCT, compared ILMP with no ILMP in MH larger than 400 microns. 39 patients were in the TB-assisted ILMP group, while 41 were in the vitrectomy-only group. The closure rate was found to be significantly higher in the former group (94.9&#37; vs. 73.2&#37;) <TextLink reference="49"></TextLink>.</Pgraph><Pgraph>A large RCT conducted by the FILMS (Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study) Group <TextLink reference="50"></TextLink> compared the effects of peeling and conventional surgery (vitrectomy only) on the rate of primary closure, visual acuity, quality of life, and expenses. Eyes with stage 2 and 3 full thickness MH of &#8804;18 months duration were included. Though the rate of primary hole closure was significantly high in the ILMP group (84&#37; vs. 48&#37;), the difference in distance, near visual acuity, and quality of life between them was not remarkable. ILMP was found to be cost-effective owing to fewer reoperations required <TextLink reference="50"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="5 Healing of macular hole">
      <MainHeadline>5 Healing of macular hole</MainHeadline><Pgraph>The improvement in post-operative visual acuity is occasionally not found to be significant despite anatomic closure of the MH. Evaluation with OCT in these cases has shown the presence of irregularities in the photoreceptor layer. Serial OCT during follow-up after MH surgery has enhanced our understanding of the healing process of the outer retina. Initially, proliferating glial cells filled the entire defect, which was seen as hyper-reflective foveal lesion on OCT. This was followed by restoration of integrity of ELM with migration of glial cells to the inner retina. Glial cell elimination was thought to help in the recovery cell bodies in the outer nuclear layer (ONL), which lead to reconstruction of the ellipsoid zone (EZ) or the inner segment&#47;outer segment (IS&#47;OS), followed by recovery of the cone interdigitation zone (CIZ) or the cone outer segment tips (COST), while glial cells disappeared completely <TextLink reference="51"></TextLink>, <TextLink reference="52"></TextLink>. Absence of disrupted ELM in the presence of intact IS&#47;OS junction has led to the assumption that restoration of ELM is critical for the healing of the photoreceptor microstructure <TextLink reference="53"></TextLink>. Earlier recovery of ELM and glial cell elimination favored complete restoration of photoreceptors, which in turn correlated positively with postoperative BCVA <TextLink reference="51"></TextLink>. Foveal cyst or outer retinal defect develop during the process of healing and disappear in about 45&#37; of the cases with the recovery of the IS&#47;OS line <TextLink reference="52"></TextLink>. This has also been described as foveal lucency, which was shown to appear in 26&#37; of the cases and disappear between 3 and 11 months after surgery, resulting in improvement of visual acuity <TextLink reference="54"></TextLink>.</Pgraph><Pgraph>Multiple healing patterns of MH have been described based on the OCT scan. Tornambe <TextLink reference="55"></TextLink> has defined the MH surgery outcome as &#8216;elevated open&#8217; if the edges are visible and elevated due to fluid underneath, as &#8216;flat open&#8217; if the hole is visible but is in contact with RPE, and as &#8216;flat closed&#8217; if the edges of the hole are not visible and the NSR is flat against RPE <TextLink reference="55"></TextLink>. Imai et al. <TextLink reference="56"></TextLink> described three patterns of repaired MH appearance: U type with normal foveal contour, V type with steep fovea, and W type with foveal defect of NSR. Post-operative visual acuity was the best in the U type and the worst in the W type <TextLink reference="56"></TextLink>. Kang et al. categorized MH closure into two types: type 1 if MH is closed without foveal defect, and type 2 if foveal defect persists with flattening of the rim <TextLink reference="57"></TextLink>. Rossi et al. <TextLink reference="58"></TextLink> have proposed new MH closure patterns based on SDOCT. Type 0 is for open MH with 0A, 0B, and 0C for open MH with flat, elevated, and oedematous margins respectively. Type 1 is for closed MH, which is further classified into 1A if all the layers are reconstituted, 1B if the external layers are interrupted, and 1C if the internal layers are interrupted. Type 2 includes MH closed with autologous or heterologous filling tissues. It is classified into 2A if the filling tissue extends through all the layers, 2B if there is recovery of normal inner layers, 2C if normal outer layers are reconstituted, and 2D if there is H-shaped bridging of the filling tissues <TextLink reference="58"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="6 Adverse effects">
      <MainHeadline>6 Adverse effects</MainHeadline><Pgraph>With the increasing popularity and acceptance of ILMP as an integral part of MH surgery, there has been growing concern regarding its long-term effects on the structure, and thereby on the function of the retina. There have been several reports of various complications, some attributed to the dye used, especially indocyanine green (ICG), and others to the act of peeling.</Pgraph><SubHeadline>6.1 Chormophore- or dye-related toxicity</SubHeadline><Pgraph>Dye enhances the visibility of ILM, which being a transparent structure would otherwise be difficult to visualize, resulting in increased intraoperative time with the risk of light toxicity and retinal trauma. ICG was the first dye to be used after being introduced in 2000. There have been several reports of RPE changes, visual field defects, and optic atrophy attributed to its use. Clinical studies have shown controversial reports, with some claiming ICG-assisted ILMP to result in better outcome <TextLink reference="59"></TextLink>, <TextLink reference="60"></TextLink>, <TextLink reference="61"></TextLink>, <TextLink reference="62"></TextLink>, <TextLink reference="63"></TextLink>, while some quote adverse effects and worse functional outcome related to its use <TextLink reference="63"></TextLink>, <TextLink reference="64"></TextLink>, <TextLink reference="65"></TextLink>, <TextLink reference="66"></TextLink>, <TextLink reference="67"></TextLink>. Several in-vitro and in-vivo studies have shown ICG to be toxic to RPE <TextLink reference="68"></TextLink>, <TextLink reference="69"></TextLink>, <TextLink reference="70"></TextLink>, <TextLink reference="71"></TextLink>, <TextLink reference="72"></TextLink>, <TextLink reference="73"></TextLink> and ganglion cells&#47;neuroretinal layer <TextLink reference="74"></TextLink> in dose-dependent fashion, and its effect is seen to be augmented by illumination. Furthermore, ICG persists on the macula and optic nerve head for several months as shown by some studies <TextLink reference="75"></TextLink>, <TextLink reference="76"></TextLink>, <TextLink reference="77"></TextLink>, <TextLink reference="78"></TextLink>. Haritoglou et al. <TextLink reference="79"></TextLink> and Gandorfer et al. <TextLink reference="80"></TextLink>, in their ultra-structural evaluation of ICG-assisted (0.05&#37; and 0.5&#37;, respectively) peeled ILM, found plasma membrane of M&#252;ller cells and other undetermined retinal structures, leading them to believe that ICG causes alteration of the plane of cleavage to deeper layers of the inner retina beyond ILM <TextLink reference="79"></TextLink>, <TextLink reference="80"></TextLink>. Da Mata et al. <TextLink reference="81"></TextLink> on the other hand found the peeled structure to be only ILM when stained with 0.5&#37; ICG. The toxicity further depends on multiple variables like concentration, volume, and commercial form of ICG used, solution used to dilute the dye, injection under air or water, duration of ICG incubation, type and duration of illumination, size of IMH, and the amount of residual vitreous <TextLink reference="82"></TextLink>. To improve the safety profile of ICG, Grisanti et al. <TextLink reference="83"></TextLink> have recommended the use of isoosmolar ICG solutions (osmolarity &#8805;290 mosm&#47;kg) with a concentration of &#8804;1 mg&#47;ml, an incubation time of 1 minute, and thorough removal of the dye, followed by exposure to illumination for  &#8804;5 minutes <TextLink reference="83"></TextLink>. The concentration advocated to be used has been further reduced to &#8804;0.5&#37; or even &#8804;0.05&#37; with use of 5&#37; glucose as diluting agent to achieve isoosmolar solution <TextLink reference="11"></TextLink>.</Pgraph><Pgraph>Infracyanine (IfCG) being devoid of iodine and isoosmolar is presumed to be safer, and this is supported by an in-vitro study in which no irreversible damage occurred to RPE and M&#252;ller cells <TextLink reference="84"></TextLink>. This was further substantiated by an animal study in which retinal injury induced by subretinal injection of 0.5&#37; IfCG was much less significant than that by 0.05&#37; ICG <TextLink reference="85"></TextLink>. On the other hand, some studies have shown that retinal toxicity rendered by both the dyes is of similar scale <TextLink reference="86"></TextLink>, <TextLink reference="87"></TextLink>.</Pgraph><Pgraph>Trypan blue (TB) is used to stain the anterior capsule during cataract surgery and is known to be safe. With the reports of ICG toxicity on the rise, there was an inclination towards the search for other options. TB was found to stain the epiretinal membrane, but also, in a more subtle manner, the ILM. In-vitro studies have shown variable results at a higher dose, however, it is found to be non-toxic to RPE and NSR at a lower dose with and without light <TextLink reference="88"></TextLink>, <TextLink reference="89"></TextLink>. Kodjikian et al. <TextLink reference="90"></TextLink> showed that TB had detrimental effects on cultured human RPE cells when exposed for 6 days, but had no such effect on acute exposure (5 mins) irrespective of doses. On the contrary, no adverse effect was seen on RPE with acute (3 mins) or chronic (72 hrs) exposure of TB at any dose in other studies <TextLink reference="91"></TextLink>, <TextLink reference="92"></TextLink>. However, time- and dose-dependent neurotoxicity with the use of TB in the laboratory has been reported <TextLink reference="93"></TextLink>. The concentration of 0.02&#37; to 0.06&#37; is considered safe <TextLink reference="94"></TextLink>. Clinical studies have been favorable towards TB in comparison to ICG, with better functional outcome and fewer adverse effects <TextLink reference="95"></TextLink>, <TextLink reference="96"></TextLink>, <TextLink reference="97"></TextLink>, while some have reported a similar outcome for both the dyes <TextLink reference="48"></TextLink>, <TextLink reference="98"></TextLink>. One issue with the application of TB is the need of air fluid exchange for it to stain the ILM. To avoid this and to make reapplication feasible, a heavier form was formulated by mixing it with 10&#37; glucose in a 1:1 ratio, which was found to be equally safe <TextLink reference="99"></TextLink>.</Pgraph><Pgraph>Brilliant blue G (BBG) was introduced by Hisatomi et al. <TextLink reference="100"></TextLink> and Enaida et al. <TextLink reference="101"></TextLink> as a dye capable of staining capsule and ILM as brilliantly as ICG, but with much less propensity for cytotoxicity as well as phototoxicity, and with an advantage of being user-friendly. In a study comparing BBG 0.05&#37;, TB 0.15&#37;, and ICG 0.5&#37;, BBG was declared superior in terms of ease of use, was comparable to TB in surgical outcomes, and almost similar to ICG as far as staining property was concerned <TextLink reference="97"></TextLink>. A meta-analysis has concluded that even though the MH closure rate is comparable, functional outcome is superior with the use of BBG than with other dyes <TextLink reference="102"></TextLink>. Another meta-analysis using ranked probability results has found that the probability of achieving MH closure is significantly higher with the use of BBG than with TA, TB, ICG, or without dye <TextLink reference="103"></TextLink>.</Pgraph><Pgraph>Triamcinolone acetate (TA) is best known for staining vitreous in vitreoretinal surgery. Since its particles settle on the ILM, it can thereby help in identification and peeling of the ILM. According to a meta-analysis comparing outcomes of 4 different dyes and no dye, the highest probability of attaining success in terms of visual outcome was with the use of TA, and following in decreasing order were BBG, TB, no dye, and ICG <TextLink reference="103"></TextLink>. A concern with the use of TA in MH surgery is deposition of its particles within the hole, which was thought to hinder its healing process or cause re-opening <TextLink reference="104"></TextLink>. However, some have observed no interference of such deposits on anatomical and functional success <TextLink reference="105"></TextLink>, <TextLink reference="106"></TextLink>, <TextLink reference="107"></TextLink>.  Animal studies have shown that doses up to 16 mg are safe, and retinal and RPE changes begin to show when the dose is escalated to 20 mg <TextLink reference="108"></TextLink>, <TextLink reference="109"></TextLink>, <TextLink reference="110"></TextLink>, <TextLink reference="111"></TextLink>.</Pgraph><SubHeadline>6.2 Structural changes</SubHeadline><SubHeadline2>6.2.1 Swelling of the arcuate nerve fiber layer (SANFL)</SubHeadline2><Pgraph>Transient increase in RNFL in the macular area is noticed as early as within 10 days of surgery and progressively reverts to baseline within 2 months. On infrared (IR) and autofluorescence (AF) photographs, this appears as dark thick stria arising from the edge of the optic nerve head (ONH) and extending towards the macula in an arcuate fashion. On scanning of the corresponding section by spectral domain OCT (SDOCT), swelling of the arcuate NFL is revealed. SANFL is not visible on clinical examination or fundus photographs. It has however been shown to have no effect on the visual outcome. Inadvertent injury to the inner retina during peeling leading to disruption of axoplasmic flow along the nerves is thought to be one of the causes, and damage to M&#252;ller cell endplates due to the act of ILMP another one <TextLink reference="112"></TextLink>.</Pgraph><SubHeadline2>6.2.2 Dissociated optic nerve fiber layer (DONFL)</SubHeadline2><Pgraph>DONFL was first described by Tadayoni et al. <TextLink reference="113"></TextLink> after ERM surgery as multiple arcuate striae running along the course of the nerve fiber in the macular area, which were relatively darker than the surrounding retina on blue filter photographs. It could also be seen on red free photographs and on fundus examination, albeit faintly. It was seen in 43&#37; of Tadayoni et al.&#8217;s cases 3 months after ERM surgery <TextLink reference="113"></TextLink>. Of the 23&#37; of the ERM specimens sent for analysis, ILM was present in all of them, but DONFL was seen in only 35.7&#37; of these <TextLink reference="113"></TextLink>. Thereafter, there were others who reported the occurrence of DONFL following ILMP for idiopathic MH <TextLink reference="114"></TextLink>, <TextLink reference="115"></TextLink>. On OCT, there were pittings or dimples in the inner retinal layer corresponding to the striae, which were not connected with each other. Mitamura et al. <TextLink reference="116"></TextLink> found the depth of dimples to be less than the RNFL thickness, while in a study by Nukada, the dimples extended to variable depths from RNFL to IPL, with the deeper ones being more in the temporal macula, which may have been more evident because of thinning of the temporal macula. The number of dimples on the other hand was the least in the temporal region, followed by nasal, inferior, and superior in increasing order <TextLink reference="117"></TextLink>. Alkabes et al. <TextLink reference="118"></TextLink> described the appearance of DONFL on en face OCT as multiple dark spots along the course of NFL, terming them &#8216;concentric macular dark spots&#8217; (CMDs). It is observed to occur between 1&#8211;3 months in the macular area denuded of ILM with no spontaneous resolution. Liu et al. <TextLink reference="118"></TextLink> reported three patterns of distribution: dark striae running along the nerve fibers sparing temporal raphe; the second type is concentrating over the papillomacular bundle; and the final type is scattered over the peeled area, which was more commonly seen in myopic eyes. Progression in terms of increase in number and size was noted up to 6 months <TextLink reference="119"></TextLink>, <TextLink reference="120"></TextLink>. There have been a few speculations regarding what it is and how it came to be. Tadayoni et al. <TextLink reference="113"></TextLink> attributed the peculiar appearance to the dissociation or separation of optic nerve fibers, which may have been the result of mechanical traction exerted by peeling of ERM and ILM, and&#47;or because of the injury to the M&#252;ller cells, which bundles up the nerve fibers together. Tadayoni et al. <TextLink reference="113"></TextLink> also had an alternative explanation, according to which the appearance of DONFL could simply be the natural rough surface of optic nerve fibers with M&#252;ller cell processes which has now been exposed after ILMP <TextLink reference="113"></TextLink>. However, the arguments against this are that the depth of the dimple is more than the thickness of ILM <TextLink reference="116"></TextLink>, extending to deeper levels, and a dimple is not seen in all the cases that undergo ILMP. Its incidence is noted to be 43&#8211;100&#37; <TextLink reference="113"></TextLink>, <TextLink reference="115"></TextLink>, <TextLink reference="118"></TextLink>, <TextLink reference="119"></TextLink>, <TextLink reference="121"></TextLink>. There are other schools of thought like the regeneration of M&#252;ller cells processes following the trauma <TextLink reference="121"></TextLink>, <TextLink reference="122"></TextLink> or the gradual degeneration of M&#252;ller cell end feet <TextLink reference="123"></TextLink> might be the probable causes of cleavage of nerve fibers leading to the typical appearance. Spaide <TextLink reference="121"></TextLink> also thought the pattern of appearance could have been because of the non-uniformity in the distribution of M&#252;ller cells, like density is more between nerve fiber bundles; hence following avulsion of M&#252;ller cell endplates, the alterations are more evident in such areas. The void created by such avulsion is initially masked by RNFL swelling which shows itself after the swelling subsides <TextLink reference="120"></TextLink>, as is observed by Clark who deduced that SANFL and DONFL are two stages of the same pathological process initiated by ILMP <TextLink reference="112"></TextLink>. Spaide observed localized thinning of the ganglion cell layer (GCL) in the areas with dimples, which was thought to be due to the loss of M&#252;ller cells or their processes, because loss of ganglion cells would mean attenuation of RNFL proximal to dimple and visual field defects <TextLink reference="121"></TextLink>, but DONFL is not associated with poor visual acuity or decreased retinal sensitivity or visual field defects <TextLink reference="113"></TextLink>, <TextLink reference="115"></TextLink>, <TextLink reference="48"></TextLink>, <TextLink reference="124"></TextLink>. Focal macular electroretinogram post-ILMP has resulted in delayed and limited recovery of b-wave amplitude, suggestive of M&#252;ller cell injury <TextLink reference="125"></TextLink>. The severity of DONFL has been found to be associated with the amount and the size of cellular debris on the retinal side of the peeled ILM <TextLink reference="126"></TextLink>. The choice of instrument &#8211; forceps vs. diamond-dusted membrane scraper (DDMS) &#8211; used for the entire peel also determines its prevalence and the extent. DDMS, either by altering the plane of cleavage or by increasing the pressure applied on the retina, has been found to be responsible for higher frequency and severity of DONFL <TextLink reference="127"></TextLink>.</Pgraph><SubHeadline2>6.2.3 Alteration of RNFL thickness</SubHeadline2><Pgraph>Peripapillary RNFL thickness is increased within a month and has been reported to last for varying periods of time from 3 to 12 months without any corresponding visual field defect. RNFL thickness in some sectors progressively decreased to below basal level, although there is no uniformity in the reports regarding the sector involved <TextLink reference="128"></TextLink>, <TextLink reference="129"></TextLink>, <TextLink reference="130"></TextLink>. The factors thought to be associated with this occurrence are dye toxicity, intraocular fluids&#47;gases used, and direct trauma to ONH during PVD induction. However, Toba et al. <TextLink reference="130"></TextLink> in their study found that the type of dye did not play any role in the alteration of RNFL thickness.</Pgraph><SubHeadline2>6.2.4 Attenuation of ganglion cell complex (GCC)</SubHeadline2><Pgraph>GCC comprises of nerve fiber layer (NFL), ganglion cell layer (GCL), and inner plexiform layer (IPL) containing axons, cell bodies, and dendrites of ganglion cells, respectively. Baba et al. <TextLink reference="131"></TextLink> reported decrease in thickness of GCC, mostly temporal and inferior to the fovea, after 6 months of ICG-assisted ILMP, which was thought to be due to injury of GCC given its close proximity to ILM, and due to dye toxicity. Another study <TextLink reference="132"></TextLink>, however, concurred in the occurrence of thinning of GCC, and showed that it was not related to ICG. There was no significant difference in GCC thickness between the ICG and BBG group <TextLink reference="132"></TextLink>. The attenuation of GCIPL over the temporal area has been supported by Sabater et al. <TextLink reference="133"></TextLink> with the explanation that relatively thin RNFL over the temporal macula might have been unable to protect ganglion cells from toxic effects of BBG and from mechanical trauma inflicted by ILMP. SD-OCT-based analyses of cases 3&#8211;6 months after MH surgery with brilliant blue-assisted ILMP have demonstrated increase in retinal thickness medial to the fovea while thinning temporally <TextLink reference="134"></TextLink>, <TextLink reference="135"></TextLink>. However, thinning of GCL occurred on either side, more so temporally <TextLink reference="134"></TextLink>. Faria et al. <TextLink reference="135"></TextLink> found thinning of RNFL, GCL, and IPL on either side of the fovea, but significantly more on the temporal side, which they thought to have been a result of local inflammation and stretching effects. On the contrary, Sevim et al. <TextLink reference="136"></TextLink> stated that BBG-assisted ILMP caused no significant change in RNFL and GCC thickness.</Pgraph><SubHeadline2>6.2.5 Shortening of papillofoveal distance</SubHeadline2><Pgraph>With the thinning of the temporal macula, thickening of the nasal part occurred with nasal displacement of the fovea after 6 months of the surgery <TextLink reference="137"></TextLink>, <TextLink reference="138"></TextLink>, <TextLink reference="139"></TextLink>, <TextLink reference="140"></TextLink>, <TextLink reference="141"></TextLink>. These changes were also seen when ILMP was done for indication other than MH like diabetic macular edema (DME) <TextLink reference="142"></TextLink>. Kawano et al. <TextLink reference="138"></TextLink> found significant foveal migration towards disc after MH with TA-assisted ILMP, while it was not seen in the cases of spontaneous hole closure. There was no association of degree of displacement with the size of MH and the post-operative BCVA <TextLink reference="138"></TextLink>. On the contrary, a correlation was seen between the ratio of migration of the temporal retina and the basal diameter of MH in a study by Ishida et al. <TextLink reference="139"></TextLink>. Also, there was greater shifting of the temporal retina towards the optic disc than nasal <TextLink reference="139"></TextLink>. Sun et al. <TextLink reference="141"></TextLink> noticed that the position of the macula was not altered during the formation of macular hole, but after surgical closure with BBG-assisted ILMP, a new foveal pit was found nasal to the original fovea. ILM is basal lamina of the M&#252;ller cells. Histological evaluation of peeled ILM has shown small fragments of M&#252;ller cell end feet attached to its undulating part <TextLink reference="143"></TextLink>. In the absence of the structural support provided by intact M&#252;ller cells, mobility of neurosensory retina (NSR) might increase. Other hypotheses are that ILMP by some unknown cause might lead to depolymerization of microtubules, thus causing axons to shrink, or some intravitreal chemical factors interacting with exposed nerve fibers in the peeled area might cause them to shrink. The nerve fibers being anchored to the lamina cribrosa are pulled towards the disc after the shrinkage <TextLink reference="139"></TextLink>. Another explanation is that NFL follows a zigzag course following ILMP, which might cause contractile forces to act towards the optic disc. Shortening of the papillofoveal distance probably leads to stretching and thinning of the temporal retina, or the other way round might be the case. Thinning of the temporal retina might be the result of atrophy or degeneration causing the biomechanical forces to tip off to the nasal side with resultant nasal foveal migration <TextLink reference="142"></TextLink>.</Pgraph><SubHeadline>6.3 Functional changes</SubHeadline><Pgraph>There have been conflicting reports of this aspect of ILM peeling. Haritoglou et al. <TextLink reference="144"></TextLink> reported paracentral scotoma in 56.2&#37; of cases after ILMP. They were relative (27.1&#37;) and deep (72.9&#37;), single or multiple, but did not interfere with good visual acuity. They were more in the temporal region, followed by superior and inferior, and the least in the nasal area <TextLink reference="144"></TextLink>. This was confirmed by Tadayoni et al. <TextLink reference="145"></TextLink>, who &#8211; using OCT&#47;SLO microperimetry &#8211; found reduced mean differential light threshold sensitivity by 3.4 dB in addition to absolute scotoma in patients who had undergone ILMP. The etiology could be forceps-related retinal trauma or secondary degeneration <TextLink reference="11"></TextLink>. Ito et al. <TextLink reference="115"></TextLink>, on the other hand, found no scotoma by SLO microperimetry in the eyes with DONFL, nor was the BCVA and macular sensitivity measured by Humphrey 10-2 any different between the eyes with or without DONFL. Similarly, sensitivity in central 10&#176; was observed by Christensen et al. <TextLink reference="48"></TextLink> to be comparable among ICG-peeled, TB-peeled, and non-peeled groups. Runkle et al. <TextLink reference="124"></TextLink> also found no difference in the sensitivity between eyes with or without DONFL, or between the nasal and temporal quadrant in eyes with DONFL, or between ILM-peeled eye and the fellow eye. There was no difference in sensitivity when the area across DONFL and normal retina around it was evaluated with MP-1 microperimetry <TextLink reference="146"></TextLink>. And when it was assessed with MP-3 in the area around the MH after ILMP, the retinal sensitivity was unexpectedly found to be increased at both 1 and 4 months postoperatively in 84.1&#37; of the cases. The cases in which the sensitivity was decreased belonged to the older age group, which was thought to be associated with retinal recovery ability <TextLink reference="147"></TextLink>. Besides achieving anatomical success and improvement in BCVA, Cappello et al. <TextLink reference="148"></TextLink> also found an increase in the maximum reading speed and retinal sensitivity post-ILMP for MH.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="7 Alternatives">
      <MainHeadline>7 Alternatives</MainHeadline><Pgraph>The anatomical outcome of MH surgery has been excellent with ILMP, but the reports of its effects on the structure and function of the retina have been a topic of debate. This has encouraged surgeons to continue their quest for finer techniques and alternative treatment options.</Pgraph><SubHeadline>7.1 Temporal ILM flap&#47;hemi-temporal ILM peeling</SubHeadline><Pgraph>Michalewska et al. <TextLink reference="25"></TextLink> while introducing inverted ILM flap had shown it to be superior to conventional vitrectomy with ILM peeling in terms of closure rate (98&#37; vs. 88&#37;) and rate of flat&#47;open type of closure (0&#37;). With increasing reports of side effects related to ILMP, the need of a new technique was felt which would give an equally good outcome, but with a lower risk of side effects. Michalewska et al. <TextLink reference="25"></TextLink> then modified their own technique such that ILM is peeled only in the temporal quadrant over an area of 2DD up to the edge of MH, and is then reflected onto the MH. This technique gave an equally good anatomical and visual outcome as the inverted flap technique and with DONFL limited to the temporal region <TextLink reference="149"></TextLink>. Being a safe and effective technique, its indication has broadened to include large, chronic, myopic MH, those who cannot maintain prone position <TextLink reference="150"></TextLink>, <TextLink reference="151"></TextLink>, and traumatic MH <TextLink reference="152"></TextLink>. However, the cases of MH with ERM tend to result in post-operative distortion of the fovea due to recurrence of ERM in the region where ILM is not peeled <TextLink reference="150"></TextLink>.</Pgraph><Pgraph>Shiono et al. <TextLink reference="153"></TextLink> described peeling of ILM over the region temporal to MH without the formation of the flap in idiopathic MH of &#60;1000 &#181; diameter. The primary closure rate was comparable to the 360&#176; ILM peeling group (93.3&#37; vs. 92.5&#37;), and so was the post-operative gain in visual acuity. The displacement of the temporal retina was more than nasal retina in both the groups, as previously reported by Ishida et al. <TextLink reference="139"></TextLink>. Migration of nasal retina towards the optic disc was significantly less in the hemi group after one week, but the difference ceased to remain statistically significant after one month of surgery. The shift of temporal retina towards the optic disc was similar in both groups. The effects beyond one month post-operative period is not known <TextLink reference="153"></TextLink>.</Pgraph><SubHeadline>7.2 ILM abrasion</SubHeadline><Pgraph>A novel technique of MH surgery by ILM abrasion in 1DD area around the MH using diamond-dusted membrane scraper (DDMS) with promising results of a 94&#37; closure rate has been introduced. Using the more rounded surface, the scraper is moved over the macular surface &#8211; first in a circumferential manner around the hole at the distance of 1DD, and then in a radial manner from the same distance toward the hole in multiple strokes all around the hole. The study included MH of stages 2, 3, and 4, and there was no significant difference in closure rates between the first and the latter two stages. None of the closed MH reopened during 3&#8211;12 months of the follow-up period. Visual acuity of &#8805;20&#47;40 was attained in 35&#37; and that of &#8805;20&#47;50 in 52&#37; three months after surgery <TextLink reference="154"></TextLink>. This technique, when done with the right amount of pressure, removes only cellular membrane and the surface layer of ILM, which has been found to be enough to initiate the reparative process. This avoids damage of other sensitive inner layers. However, if the pressure is less, ERM is not completely removed, which may lead to failure of closure of the hole. On the other hand, if the pressure is more, it leads to disruption of ILM and possible damage of NFL <TextLink reference="155"></TextLink>.</Pgraph><SubHeadline>7.3 Ocriplasmin (OCP)</SubHeadline><Pgraph>Ocriplasmin is a truncated human plasmin when injected at the dose of 125 &#181;g&#47;0.1 ml lyses laminin and fibronectin, two of the components of vitreo-retinal interface causing posterior vitreous detachment. RCT have shown that it causes closure of MH of less than 400 &#181; diameter associated with vitreomacular adhesion (VMA) in 30&#8211;40.6&#37; <TextLink reference="156"></TextLink>, <TextLink reference="157"></TextLink>. The success is greater in eyes with MH &#8804;250 &#181; diameter (47.8&#8211;58.3&#37;) in comparison to MH of &#62;250&#8211;400 &#181; diameter (23.5&#8211;36.8&#37;) <TextLink reference="156"></TextLink>, <TextLink reference="158"></TextLink>. With the anatomical success, improvement in visual function was also obtained as indicated by BCVA and the 25-item visual function questionnaire (VFQ-25). BCVA at 6 months improved by &#8805;2 lines in 72.1&#37;, and by &#8805;3 lines in 48.8&#37; of the FTMH cases which had achieved closure by day 28, together with better scores in VFQ-25 assessment in comparison to the ones which had not achieved closure by the given time <TextLink reference="159"></TextLink>. Reopening of MH occurred in 9.3&#37; <TextLink reference="160"></TextLink>. PPV for persistent VMT&#47;MH following administration of OCP had a similar outcome as PPV-only <TextLink reference="161"></TextLink>, <TextLink reference="162"></TextLink>. With experience it has been known that OCP works best when certain criteria are met, such as age &#8804;65 years, phakic lens status, FTMH &#60;250 &#181;, VMA &#60;1500 &#181;, absence of ERM, macular pucker, diabetic retinopathy, and history of previous intraocular surgery <TextLink reference="163"></TextLink>.</Pgraph><Pgraph>Regarding its safety profile, MIVI TRUST and OASIS have reported adverse effects to be mild and transient. Floaters was the most common adverse event, followed by photopsia <TextLink reference="156"></TextLink>, <TextLink reference="157"></TextLink>. Hahn et al. <TextLink reference="164"></TextLink>, in a study analyzing pre-marketing and post-marketing adverse effects of OCP, divided it into eight groups: acute reduction in vision secondary to progression of VMT and&#47;or MH or to occurrence of sub retinal fluid, electroretinogram (ERG) changes, dyschromatopsia, retinal tears and detachments, lens subluxation and phacodonesis, impaired pupillary reflex, ellipsoid zone findings, and retinal vessel findings. Nyctalopia with reduction of a and b wave amplitudes on scotopic ERG has been reported <TextLink reference="165"></TextLink>. The panretinal abnormalities are thought to be due to the action of OCP on laminin present throughout the retina and in various layers namely the Bruch&#8217;s membrane, the interphotoreceptor matrix, the external limiting membrane, the outer plexiform layer, the inner plexiform layer, and the internal limiting membrane <TextLink reference="166"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="8 Conclusion">
      <MainHeadline>8 Conclusion</MainHeadline><Pgraph>ILMP since its introduction has been embraced by VR surgeons for the surgeries related to VRI including MH. Adverse effects related to it, however, have been of concern, and as a result have led to several modifications and search for alternatives. Temporal ILM flap has emerged as an equally effective procedure with the added benefit of a limited area of structural changes. Future prospective randomized studies with long-term follow-up can compare the newer techniques with ILMP in terms of anatomical and functional outcome. Vitrectomy alone also has shown successful anatomical results in MH &#60;400 &#181;. If the risk related to vitrectomy is also to be avoided, OCP can be an option especially for MH &#60;250 &#181;, but with a lower success rate and its own list of side effects. The risks, benefits, and cost effectiveness of each procedure should be weighed and discussed with the patient before deciding on the mode of treatment.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Notes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Authors&#8217; ORCIDs</SubHeadline><Pgraph><UnorderedList><ListItem level="1">Deepti Pradhan: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-2595-181X">0000-0002-2595-181X</Hyperlink></ListItem><ListItem level="1">Lalit Agarwal: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-2681-768X">0000-0002-2681-768X</Hyperlink></ListItem><ListItem level="1">Ichhya Joshi: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-1813-6008">0000-0002-1813-6008</Hyperlink></ListItem><ListItem level="1">Anamika Kushwaha: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-6953-8250">0000-0002-6953-8250</Hyperlink></ListItem><ListItem level="1">Kshitij Aditya: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-9276-7756">0000-0002-9276-7756</Hyperlink></ListItem><ListItem level="1">Archana Kumari: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0001-7930-9446">0000-0001-7930-9446</Hyperlink></ListItem></UnorderedList></Pgraph><SubHeadline>Acknowledgment</SubHeadline><Pgraph>The authors are grateful to Mr. Shailendra Jha and Ms. Theresa Weippert for helping with the translation of the title and the abstract into German.</Pgraph><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Sharma YR</RefAuthor>
        <RefAuthor>Sudan R</RefAuthor>
        <RefAuthor>Gaur A</RefAuthor>
        <RefAuthor>Reddy RR</RefAuthor>
        <RefTitle>Macular hole</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>JK Science</RefJournal>
        <RefPage>57-70</RefPage>
        <RefTotal>Sharma YR, Sudan R, Gaur A, Reddy RR. Macular hole. JK Science. 2002 Apr-Jun;4(2):57-70.</RefTotal>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Coats G</RefAuthor>
        <RefTitle>The pathology of macular holes</RefTitle>
        <RefYear>1907</RefYear>
        <RefJournal>Roy London Hosp Rep</RefJournal>
        <RefPage>69-96</RefPage>
        <RefTotal>Coats G. The pathology of macular holes. Roy London Hosp Rep. 1907;17:69-96.</RefTotal>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Reese AB</RefAuthor>
        <RefAuthor>Jones IS</RefAuthor>
        <RefAuthor>Cooper WC</RefAuthor>
        <RefTitle>Macular changes secondary to vitreous traction</RefTitle>
        <RefYear>1967</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>544-9</RefPage>
        <RefTotal>Reese AB, Jones IS, Cooper WC. Macular changes secondary to vitreous traction. Am J Ophthalmol. 1967 Sep;64(3):Suppl:544-9. DOI: 10.1016&#47;0002-9394(67)90557-0</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;0002-9394(67)90557-0</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Schepens CL</RefAuthor>
        <RefTitle>Fundus changes caused by alterations of the vitreous body</RefTitle>
        <RefYear>1955</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>631-3</RefPage>
        <RefTotal>Schepens CL. Fundus changes caused by alterations of the vitreous body. Am J Ophthalmol. 1955 May;39(5):631-3. DOI: 10.1016&#47;0002-9394(55)90033-7</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;0002-9394(55)90033-7</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Avila MP</RefAuthor>
        <RefAuthor>Jalkh AE</RefAuthor>
        <RefAuthor>Murakami K</RefAuthor>
        <RefAuthor>Trempe CL</RefAuthor>
        <RefAuthor>Schepens CL</RefAuthor>
        <RefTitle>Biomicroscopic study of the vitreous in macular breaks</RefTitle>
        <RefYear>1983</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1277-83</RefPage>
        <RefTotal>Avila MP, Jalkh AE, Murakami K, Trempe CL, Schepens CL. Biomicroscopic study of the vitreous in macular breaks. Ophthalmology. 1983 Nov;90(11):1277-83. DOI: 10.1016&#47;s0161-6420(83)34391-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0161-6420(83)34391-8</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Kakehashi A</RefAuthor>
        <RefAuthor>Schepens CL</RefAuthor>
        <RefAuthor>Trempe CL</RefAuthor>
        <RefTitle>Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks</RefTitle>
        <RefYear>1996</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>425-33</RefPage>
        <RefTotal>Kakehashi A, Schepens CL, Trempe CL. Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks. Graefes Arch Clin Exp Ophthalmol. 1996 Jul;234(7):425-33. DOI: 10.1007&#47;BF02539408</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;BF02539408</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Gass JD</RefAuthor>
        <RefTitle>Idiopathic senile macular hole. Its early stages and pathogenesis</RefTitle>
        <RefYear>1988</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>629-39</RefPage>
        <RefTotal>Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol. 1988 May;106(5):629-39. DOI: 10.1001&#47;archopht.1988.01060130683026</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.1988.01060130683026</RefLink>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Gaudric A</RefAuthor>
        <RefAuthor>Haouchine B</RefAuthor>
        <RefAuthor>Massin P</RefAuthor>
        <RefAuthor>Paques M</RefAuthor>
        <RefAuthor>Blain P</RefAuthor>
        <RefAuthor>Erginay A</RefAuthor>
        <RefTitle>Macular hole formation: new data provided by optical coherence tomography</RefTitle>
        <RefYear>1999</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>744-51</RefPage>
        <RefTotal>Gaudric A, Haouchine B, Massin P, Paques M, Blain P, Erginay A. Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol. 1999 Jun;117(6):744-51. DOI: 10.1001&#47;archopht.117.6.744</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.117.6.744</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Tanner V</RefAuthor>
        <RefAuthor>Chauhan DS</RefAuthor>
        <RefAuthor>Jackson TL</RefAuthor>
        <RefAuthor>Williamson TH</RefAuthor>
        <RefTitle>Optical coherence tomography of the vitreoretinal interface in macular hole formation</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1092-7</RefPage>
        <RefTotal>Tanner V, Chauhan DS, Jackson TL, Williamson TH. Optical coherence tomography of the vitreoretinal interface in macular hole formation. Br J Ophthalmol. 2001 Sep;85(9):1092-7. DOI: 10.1136&#47;bjo.85.9.1092</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.85.9.1092</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Fine BS</RefAuthor>
        <RefTitle>Limiting membranes of the sensory retina and pigment epithelium. An electron microscopic study</RefTitle>
        <RefYear>1961</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>847-60</RefPage>
        <RefTotal>Fine BS. Limiting membranes of the sensory retina and pigment epithelium. An electron microscopic study. Arch Ophthalmol. 1961 Dec;66:847-60. DOI: 10.1001&#47;archopht.1961.00960010849012</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.1961.00960010849012</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Morescalchi F</RefAuthor>
        <RefAuthor>Costagliola C</RefAuthor>
        <RefAuthor>Gambicorti E</RefAuthor>
        <RefAuthor>Duse S</RefAuthor>
        <RefAuthor>Romano MR</RefAuthor>
        <RefAuthor>Semeraro F</RefAuthor>
        <RefTitle>Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Surv Ophthalmol</RefJournal>
        <RefPage>58-69</RefPage>
        <RefTotal>Morescalchi F, Costagliola C, Gambicorti E, Duse S, Romano MR, Semeraro F. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery. Surv Ophthalmol. 2017 Jan-Feb;62(1):58-69. DOI: 10.1016&#47;j.survophthal.2016.07.003</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.survophthal.2016.07.003</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Gass JD</RefAuthor>
        <RefTitle>Reappraisal of biomicroscopic classification of stages of development of a macular hole</RefTitle>
        <RefYear>1995</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>752-9</RefPage>
        <RefTotal>Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995 Jun;119(6):752-9. DOI: 10.1016&#47;s0002-9394(14)72781-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(14)72781-3</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Duker JS</RefAuthor>
        <RefAuthor>Kaiser PK</RefAuthor>
        <RefAuthor>Binder S</RefAuthor>
        <RefAuthor>de Smet MD</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefAuthor>Reichel E</RefAuthor>
        <RefAuthor>Sadda SR</RefAuthor>
        <RefAuthor>Sebag J</RefAuthor>
        <RefAuthor>Spaide RF</RefAuthor>
        <RefAuthor>Stalmans P</RefAuthor>
        <RefTitle>The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2611-9</RefPage>
        <RefTotal>Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013 Dec;120(12):2611-9. DOI: 10.1016&#47;j.ophtha.2013.07.042</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2013.07.042</RefLink>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Garcia JH</RefAuthor>
        <RefAuthor>Johnson M</RefAuthor>
        <RefAuthor>Shah G</RefAuthor>
        <RefAuthor>Meyer CH</RefAuthor>
        <RefAuthor>Melo GB</RefAuthor>
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefTitle>Macular microhole and foveal red spot syndrome: a critical review of the literature</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>1685-94</RefPage>
        <RefTotal>Garcia JH, Johnson M, Shah G, Meyer CH, Melo GB, Rodrigues EB. Macular microhole and foveal red spot syndrome: a critical review of the literature. Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1685-94. DOI: 10.1007&#47;s00417-020-04995-z</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-020-04995-z</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Bhavsar AR</RefAuthor>
        <RefAuthor>Gomez J</RefAuthor>
        <RefAuthor>Kelly NE</RefAuthor>
        <RefAuthor>Wendel R</RefAuthor>
        <RefTitle>Macular hole surgery: a review of past, present and latest treatments for macular hole</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Expert Rev Ophthalmol</RefJournal>
        <RefPage>443-53</RefPage>
        <RefTotal>Bhavsar AR, Gomez J, Kelly NE, Wendel R. Macular hole surgery: a review of past, present and latest treatments for macular hole. Expert Rev Ophthalmol. 2014;9(5):443-53.</RefTotal>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Kelly NE</RefAuthor>
        <RefAuthor>Wendel RT</RefAuthor>
        <RefTitle>Vitreous surgery for idiopathic macular holes. Results of a pilot study</RefTitle>
        <RefYear>1991</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>654-9</RefPage>
        <RefTotal>Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991 May;109(5):654-9. DOI: 10.1001&#47;archopht.1991.01080050068031</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.1991.01080050068031</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Eckardt C</RefAuthor>
        <RefAuthor>Eckardt U</RefAuthor>
        <RefAuthor>Groos S</RefAuthor>
        <RefAuthor>Luciano L</RefAuthor>
        <RefAuthor>Reale E</RefAuthor>
        <RefTitle>Entfernung der Membrana limitans interna bei Makulal&#246;chern. Klinische und morphologische Befunde</RefTitle>
        <RefYear>1997</RefYear>
        <RefJournal>Ophthalmologe</RefJournal>
        <RefPage>545-51</RefPage>
        <RefTotal>Eckardt C, Eckardt U, Groos S, Luciano L, Reale E. Entfernung der Membrana limitans interna bei Makulal&#246;chern. Klinische und morphologische Befunde &#91;Removal of the internal limiting membrane in macular holes. Clinical and morphological findings&#93;. Ophthalmologe. 1997 Aug;94(8):545-51. DOI: 10.1007&#47;s003470050156</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s003470050156</RefLink>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Park DW</RefAuthor>
        <RefAuthor>Lee JH</RefAuthor>
        <RefAuthor>Min WK</RefAuthor>
        <RefTitle>The use of internal limiting membrane maculorrhexis in treatment of idiopathic macular holes</RefTitle>
        <RefYear>1998</RefYear>
        <RefJournal>Korean J Ophthalmol</RefJournal>
        <RefPage>92-7</RefPage>
        <RefTotal>Park DW, Lee JH, Min WK. The use of internal limiting membrane maculorrhexis in treatment of idiopathic macular holes. Korean J Ophthalmol. 1998 Dec;12(2):92-7. DOI: 10.3341&#47;kjo.1998.12.2.92</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3341&#47;kjo.1998.12.2.92</RefLink>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Morris R</RefAuthor>
        <RefAuthor>Witherspoon D</RefAuthor>
        <RefTitle>Video presentation at The American Society of Retina Specialists (ASRS)</RefTitle>
        <RefYear></RefYear>
        <RefBookTitle>Vitreous Society Annual Meeting; 1998 Jul; Alaska</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Morris R, Witherspoon D. Video presentation at The American Society of Retina Specialists (ASRS). Vitreous Society Annual Meeting; 1998 Jul; Alaska.</RefTotal>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefAuthor>Meyer CH</RefAuthor>
        <RefAuthor>Kroll P</RefAuthor>
        <RefTitle>Chromovitrectomy: a new field in vitreoretinal surgery</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>291-3</RefPage>
        <RefTotal>Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):291-3. DOI: 10.1007&#47;s00417-004-0992-x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-004-0992-x</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Farah ME</RefAuthor>
        <RefAuthor>Maia M</RefAuthor>
        <RefAuthor>Penha FM</RefAuthor>
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefTitle>The Use of Vital Dyes during Vitreoretinal Surgery &#8211; Chromovitrectomy</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Dev Ophthalmol</RefJournal>
        <RefPage>365-75</RefPage>
        <RefTotal>Farah ME, Maia M, Penha FM, Rodrigues EB. The Use of Vital Dyes during Vitreoretinal Surgery &#8211; Chromovitrectomy. Dev Ophthalmol. 2016;55:365-75. DOI: 10.1159&#47;000438963</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1159&#47;000438963</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Bae K</RefAuthor>
        <RefAuthor>Kang SW</RefAuthor>
        <RefAuthor>Kim JH</RefAuthor>
        <RefAuthor>Kim SJ</RefAuthor>
        <RefAuthor>Kim JM</RefAuthor>
        <RefAuthor>Yoon JM</RefAuthor>
        <RefTitle>Extent of Internal Limiting Membrane Peeling and its Impact on Macular Hole Surgery Outcomes: A Randomized Trial</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>179-88</RefPage>
        <RefTotal>Bae K, Kang SW, Kim JH, Kim SJ, Kim JM, Yoon JM. Extent of Internal Limiting Membrane Peeling and its Impact on Macular Hole Surgery Outcomes: A Randomized Trial. Am J Ophthalmol. 2016 Sep;169:179-88. DOI: 10.1016&#47;j.ajo.2016.06.041</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2016.06.041</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Goker YS</RefAuthor>
        <RefAuthor>Koc M</RefAuthor>
        <RefAuthor>Yuksel K</RefAuthor>
        <RefAuthor>Yazici AT</RefAuthor>
        <RefAuthor>Demir A</RefAuthor>
        <RefAuthor>Gunes H</RefAuthor>
        <RefAuthor>Ozpinar Y</RefAuthor>
        <RefTitle>Relationship between Peeled Internal Limiting Membrane Area and Anatomic Outcomes following Macular Hole Surgery: A Quantitative Analysis</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>5641273</RefPage>
        <RefTotal>Goker YS, Koc M, Yuksel K, Yazici AT, Demir A, Gunes H, Ozpinar Y. Relationship between Peeled Internal Limiting Membrane Area and Anatomic Outcomes following Macular Hole Surgery: A Quantitative Analysis. J Ophthalmol. 2016;2016:5641273. DOI: 10.1155&#47;2016&#47;5641273</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2016&#47;5641273</RefLink>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>Yao Y</RefAuthor>
        <RefAuthor>Qu J</RefAuthor>
        <RefAuthor>Dong C</RefAuthor>
        <RefAuthor>Li X</RefAuthor>
        <RefAuthor>Liang J</RefAuthor>
        <RefAuthor>Yin H</RefAuthor>
        <RefAuthor>Huang L</RefAuthor>
        <RefAuthor>Li Y</RefAuthor>
        <RefAuthor>Liu P</RefAuthor>
        <RefAuthor>Pan C</RefAuthor>
        <RefAuthor>Ding X</RefAuthor>
        <RefAuthor>Song D</RefAuthor>
        <RefAuthor>Sadda SR</RefAuthor>
        <RefAuthor>Zhao M</RefAuthor>
        <RefTitle>The impact of extent of internal limiting membrane peeling on anatomical outcomes of macular hole surgery: results of a 54-week randomized clinical trial</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Acta Ophthalmol</RefJournal>
        <RefPage>303-12</RefPage>
        <RefTotal>Yao Y, Qu J, Dong C, Li X, Liang J, Yin H, Huang L, Li Y, Liu P, Pan C, Ding X, Song D, Sadda SR, Zhao M. The impact of extent of internal limiting membrane peeling on anatomical outcomes of macular hole surgery: results of a 54-week randomized clinical trial. Acta Ophthalmol. 2019 May;97(3):303-12. DOI: 10.1111&#47;aos.13853</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;aos.13853</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>Michalewska Z</RefAuthor>
        <RefAuthor>Michalewski J</RefAuthor>
        <RefAuthor>Adelman RA</RefAuthor>
        <RefAuthor>Nawrocki J</RefAuthor>
        <RefTitle>Inverted internal limiting membrane flap technique for large macular holes</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2018-25</RefPage>
        <RefTotal>Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010 Oct;117(10):2018-25. DOI: 10.1016&#47;j.ophtha.2010.02.011</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2010.02.011</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Zhao PP</RefAuthor>
        <RefAuthor>Wang S</RefAuthor>
        <RefAuthor>Liu N</RefAuthor>
        <RefAuthor>Shu ZM</RefAuthor>
        <RefAuthor>Zhao JS</RefAuthor>
        <RefTitle>A Review of Surgical Outcomes and Advances for Macular Holes</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>7389412</RefPage>
        <RefTotal>Zhao PP, Wang S, Liu N, Shu ZM, Zhao JS. A Review of Surgical Outcomes and Advances for Macular Holes. J Ophthalmol. 2018;2018:7389412. DOI: 10.1155&#47;2018&#47;7389412</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2018&#47;7389412</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Kase S</RefAuthor>
        <RefAuthor>Saito W</RefAuthor>
        <RefAuthor>Mori S</RefAuthor>
        <RefAuthor>Saito M</RefAuthor>
        <RefAuthor>Ando R</RefAuthor>
        <RefAuthor>Dong Z</RefAuthor>
        <RefAuthor>Suzuki T</RefAuthor>
        <RefAuthor>Noda K</RefAuthor>
        <RefAuthor>Ishida S</RefAuthor>
        <RefTitle>Clinical and histological evaluation of large macular hole surgery using the inverted internal limiting membrane flap technique</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Clin Ophthalmol</RefJournal>
        <RefPage>9-14</RefPage>
        <RefTotal>Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Noda K, Ishida S. Clinical and histological evaluation of large macular hole surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2017;11:9-14. DOI: 10.2147&#47;OPTH.S119762</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;OPTH.S119762</RefLink>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Shin MK</RefAuthor>
        <RefAuthor>Park KH</RefAuthor>
        <RefAuthor>Park SW</RefAuthor>
        <RefAuthor>Byon IS</RefAuthor>
        <RefAuthor>Lee JE</RefAuthor>
        <RefTitle>Perfluoro-n-octane-assisted single-layered inverted internal limiting membrane flap technique for macular hole surgery</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1905-10</RefPage>
        <RefTotal>Shin MK, Park KH, Park SW, Byon IS, Lee JE. Perfluoro-n-octane-assisted single-layered inverted internal limiting membrane flap technique for macular hole surgery. Retina. 2014 Sep;34(9):1905-10. DOI: 10.1097&#47;IAE.0000000000000339</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000339</RefLink>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Pak KY</RefAuthor>
        <RefAuthor>Park JY</RefAuthor>
        <RefAuthor>Park SW</RefAuthor>
        <RefAuthor>Byon IS</RefAuthor>
        <RefAuthor>Lee JE</RefAuthor>
        <RefTitle>Efficacy of the Perfluoro-N-Octane-Assisted Single-Layered Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Ophthalmologica</RefJournal>
        <RefPage>133-8</RefPage>
        <RefTotal>Pak KY, Park JY, Park SW, Byon IS, Lee JE. Efficacy of the Perfluoro-N-Octane-Assisted Single-Layered Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes. Ophthalmologica. 2017;238(3):133-8. DOI: 10.1159&#47;000477823</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1159&#47;000477823</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Song Z</RefAuthor>
        <RefAuthor>Li M</RefAuthor>
        <RefAuthor>Liu J</RefAuthor>
        <RefAuthor>Hu X</RefAuthor>
        <RefAuthor>Hu Z</RefAuthor>
        <RefAuthor>Chen D</RefAuthor>
        <RefTitle>Viscoat Assisted Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes Associated with High Myopia</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>8283062</RefPage>
        <RefTotal>Song Z, Li M, Liu J, Hu X, Hu Z, Chen D. Viscoat Assisted Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes Associated with High Myopia. J Ophthalmol. 2016;2016:8283062. DOI: 10.1155&#47;2016&#47;8283062</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2016&#47;8283062</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Lai CC</RefAuthor>
        <RefAuthor>Chen YP</RefAuthor>
        <RefAuthor>Wang NK</RefAuthor>
        <RefAuthor>Chuang LH</RefAuthor>
        <RefAuthor>Liu L</RefAuthor>
        <RefAuthor>Chen KJ</RefAuthor>
        <RefAuthor>Hwang YS</RefAuthor>
        <RefAuthor>Wu WC</RefAuthor>
        <RefAuthor>Chen TL</RefAuthor>
        <RefTitle>Vitrectomy with Internal Limiting Membrane Repositioning and Autologous Blood for Macular Hole Retinal Detachment in Highly Myopic Eyes</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1889-98</RefPage>
        <RefTotal>Lai CC, Chen YP, Wang NK, Chuang LH, Liu L, Chen KJ, Hwang YS, Wu WC, Chen TL. Vitrectomy with Internal Limiting Membrane Repositioning and Autologous Blood for Macular Hole Retinal Detachment in Highly Myopic Eyes. Ophthalmology. 2015 Sep;122(9):1889-98. DOI: 10.1016&#47;j.ophtha.2015.05.040</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2015.05.040</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Chen SN</RefAuthor>
        <RefTitle>Large semicircular inverted internal limiting membrane flap in the treatment of macular hole in high myopia</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>2337-45</RefPage>
        <RefTotal>Chen SN. Large semicircular inverted internal limiting membrane flap in the treatment of macular hole in high myopia. Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2337-45. DOI: 10.1007&#47;s00417-017-3808-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-017-3808-5</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Ho TC</RefAuthor>
        <RefAuthor>Yang CM</RefAuthor>
        <RefAuthor>Huang JS</RefAuthor>
        <RefAuthor>Yang CH</RefAuthor>
        <RefAuthor>Chen MS</RefAuthor>
        <RefTitle>Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>1553-60</RefPage>
        <RefTotal>Ho TC, Yang CM, Huang JS, Yang CH, Chen MS. Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole. Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1553-60. DOI: 10.1007&#47;s00417-014-2613-7</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-014-2613-7</RefLink>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Morizane Y</RefAuthor>
        <RefAuthor>Shiraga F</RefAuthor>
        <RefAuthor>Kimura S</RefAuthor>
        <RefAuthor>Hosokawa M</RefAuthor>
        <RefAuthor>Shiode Y</RefAuthor>
        <RefAuthor>Kawata T</RefAuthor>
        <RefAuthor>Hosogi M</RefAuthor>
        <RefAuthor>Shirakata Y</RefAuthor>
        <RefAuthor>Okanouchi T</RefAuthor>
        <RefTitle>Autologous transplantation of the internal limiting membrane for refractory macular holes</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>861-9.e1</RefPage>
        <RefTotal>Morizane Y, Shiraga F, Kimura S, Hosokawa M, Shiode Y, Kawata T, Hosogi M, Shirakata Y, Okanouchi T. Autologous transplantation of the internal limiting membrane for refractory macular holes. Am J Ophthalmol. 2014 Apr;157(4):861-9.e1. DOI: 10.1016&#47;j.ajo.2013.12.028</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2013.12.028</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Aurora A</RefAuthor>
        <RefAuthor>Seth A</RefAuthor>
        <RefAuthor>Sanduja N</RefAuthor>
        <RefTitle>Cabbage Leaf Inverted Flap ILM Peeling for Macular Hole: A Novel Technique</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Ophthalmic Surg Lasers Imaging Retina</RefJournal>
        <RefPage>830-2</RefPage>
        <RefTotal>Aurora A, Seth A, Sanduja N. Cabbage Leaf Inverted Flap ILM Peeling for Macular Hole: A Novel Technique. Ophthalmic Surg Lasers Imaging Retina. 2017 Oct;48(10):830-2. DOI: 10.3928&#47;23258160-20170928-08</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3928&#47;23258160-20170928-08</RefLink>
      </Reference>
      <Reference refNo="36">
        <RefAuthor>Chen SN</RefAuthor>
        <RefAuthor>Yang CM</RefAuthor>
        <RefTitle>Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>163-70</RefPage>
        <RefTotal>Chen SN, Yang CM. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies. Retina. 2016 Jan;36(1):163-70. DOI: 10.1097&#47;IAE.0000000000000674</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000674</RefLink>
      </Reference>
      <Reference refNo="37">
        <RefAuthor>Grewal DS</RefAuthor>
        <RefAuthor>Mahmoud TH</RefAuthor>
        <RefTitle>Autologous Neurosensory Retinal Free Flap for Closure of Refractory Myopic Macular Holes</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>JAMA Ophthalmol</RefJournal>
        <RefPage>229-30</RefPage>
        <RefTotal>Grewal DS, Mahmoud TH. Autologous Neurosensory Retinal Free Flap for Closure of Refractory Myopic Macular Holes. JAMA Ophthalmol. 2016 Feb;134(2):229-30. DOI: 10.1001&#47;jamaophthalmol.2015.5237</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;jamaophthalmol.2015.5237</RefLink>
      </Reference>
      <Reference refNo="38">
        <RefAuthor>Felfeli T</RefAuthor>
        <RefAuthor>Mandelcorn ED</RefAuthor>
        <RefTitle>Macular Hole Hydrodissection &#8211; Surgical Technique for the Treatment of Persistent, Chronic, and Large Macular Holes</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>743-52</RefPage>
        <RefTotal>Felfeli T, Mandelcorn ED. Macular Hole Hydrodissection &#8211; Surgical Technique for the Treatment of Persistent, Chronic, and Large Macular Holes. Retina. 2019 Apr;39(4):743-52. DOI: 10.1097&#47;IAE.0000000000002013</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000002013</RefLink>
      </Reference>
      <Reference refNo="39">
        <RefAuthor>Mohammed OA</RefAuthor>
        <RefAuthor>Pai A</RefAuthor>
        <RefTitle>New Surgical Technique for Management of Recurrent Macular Hole</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Middle East Afr J Ophthalmol</RefJournal>
        <RefPage>61-3</RefPage>
        <RefTotal>Mohammed OA, Pai A. New Surgical Technique for Management of Recurrent Macular Hole. Middle East Afr J Ophthalmol. 2017 Jan-Mar;24(1):61-3. DOI: 10.4103&#47;meajo.MEAJO&#95;211&#95;15</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;meajo.MEAJO&#95;211&#95;15</RefLink>
      </Reference>
      <Reference refNo="40">
        <RefAuthor>Freeman WR</RefAuthor>
        <RefAuthor>Azen SP</RefAuthor>
        <RefAuthor>Kim JW</RefAuthor>
        <RefAuthor>el-Haig W</RefAuthor>
        <RefAuthor>Mishell DR 3rd</RefAuthor>
        <RefAuthor>Bailey I</RefAuthor>
        <RefTitle>Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group</RefTitle>
        <RefYear>1997</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>11-21</RefPage>
        <RefTotal>Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell DR 3rd, Bailey I. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol. 1997 Jan;115(1):11-21. DOI: 10.1001&#47;archopht.1997.01100150013002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.1997.01100150013002</RefLink>
      </Reference>
      <Reference refNo="41">
        <RefAuthor>Ezra E</RefAuthor>
        <RefAuthor>Gregor ZJ</RefAuthor>
        <RefAuthor> Morfields Macular Hole Study Group Report No</RefAuthor>
        <RefTitle>1. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group Report no. 1</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>224-36</RefPage>
        <RefTotal>Ezra E, Gregor ZJ; Morfields Macular Hole Study Group Report No. 1. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group Report no. 1. Arch Ophthalmol. 2004 Feb;122(2):224-36. DOI: 10.1001&#47;archopht.122.2.224</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.122.2.224</RefLink>
      </Reference>
      <Reference refNo="42">
        <RefAuthor>Brooks HL Jr</RefAuthor>
        <RefTitle>Macular hole surgery with and without internal limiting membrane peeling</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1939-48</RefPage>
        <RefTotal>Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000 Oct;107(10):1939-48. DOI: 10.1016&#47;s0161-6420(00)00331-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0161-6420(00)00331-6</RefLink>
      </Reference>
      <Reference refNo="43">
        <RefAuthor>Mester V</RefAuthor>
        <RefAuthor>Kuhn F</RefAuthor>
        <RefTitle>Internal limiting membrane removal in the management of full-thickness macular holes</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>769-77</RefPage>
        <RefTotal>Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol. 2000 Jun;129(6):769-77. DOI: 10.1016&#47;s0002-9394(00)00358-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(00)00358-5</RefLink>
      </Reference>
      <Reference refNo="44">
        <RefAuthor>Foulquier S</RefAuthor>
        <RefAuthor>Glacet-Bernard A</RefAuthor>
        <RefAuthor>Sterkers M</RefAuthor>
        <RefAuthor>Soubrane G</RefAuthor>
        <RefAuthor>Coscas G</RefAuthor>
        <RefTitle>Etude de l&#8217;ablation de la limitante interne dans la chirurgie des trous maculaires idiopathiques de stade 3 et 4</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>J Fr Ophtalmol</RefJournal>
        <RefPage>1026-31</RefPage>
        <RefTotal>Foulquier S, Glacet-Bernard A, Sterkers M, Soubrane G, Coscas G. Etude de l&#8217;ablation de la limitante interne dans la chirurgie des trous maculaires idiopathiques de stade 3 et 4 &#91;Study of internal limiting membrane peeling in stage-3 and -4 idiopathic macular hole surgery&#93;. J Fr Ophtalmol. 2002 Dec;25(10):1026-31.</RefTotal>
      </Reference>
      <Reference refNo="45">
        <RefAuthor>Sheidow TG</RefAuthor>
        <RefAuthor>Blinder KJ</RefAuthor>
        <RefAuthor>Holekamp N</RefAuthor>
        <RefAuthor>Joseph D</RefAuthor>
        <RefAuthor>Shah G</RefAuthor>
        <RefAuthor>Grand MG</RefAuthor>
        <RefAuthor>Thomas MA</RefAuthor>
        <RefAuthor>Bakal J</RefAuthor>
        <RefAuthor>Sharma S</RefAuthor>
        <RefTitle>Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1697-701</RefPage>
        <RefTotal>Sheidow TG, Blinder KJ, Holekamp N, Joseph D, Shah G, Grand MG, Thomas MA, Bakal J, Sharma S. Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology. 2003 Sep;110(9):1697-701. DOI: 10.1016&#47;S0161-6420(03)00562-1</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;S0161-6420(03)00562-1</RefLink>
      </Reference>
      <Reference refNo="46">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Schaumberger M</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Ulbig MW</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Long-term follow-up after macular hole surgery with internal limiting membrane peeling</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>661-6</RefPage>
        <RefTotal>Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol. 2002 Nov;134(5):661-6. DOI: 10.1016&#47;s0002-9394(02)01751-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(02)01751-8</RefLink>
      </Reference>
      <Reference refNo="47">
        <RefAuthor>Kwok AK</RefAuthor>
        <RefAuthor>Lai TY</RefAuthor>
        <RefAuthor>Wong VW</RefAuthor>
        <RefTitle>Idiopathic macular hole surgery in Chinese patients: a randomised study to compare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Hong Kong Med J</RefJournal>
        <RefPage>259-66</RefPage>
        <RefTotal>Kwok AK, Lai TY, Wong VW. Idiopathic macular hole surgery in Chinese patients: a randomised study to compare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J. 2005 Aug;11(4):259-66.</RefTotal>
      </Reference>
      <Reference refNo="48">
        <RefAuthor>Christensen UC</RefAuthor>
        <RefAuthor>Kr&#248;yer K</RefAuthor>
        <RefAuthor>Sander B</RefAuthor>
        <RefAuthor>Larsen M</RefAuthor>
        <RefAuthor>Henning V</RefAuthor>
        <RefAuthor>Villumsen J</RefAuthor>
        <RefAuthor>la Cour M</RefAuthor>
        <RefTitle>Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1005-15</RefPage>
        <RefTotal>Christensen UC, Kr&#248;yer K, Sander B, Larsen M, Henning V, Villumsen J, la Cour M. Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol. 2009 Aug;93(8):1005-15. DOI: 10.1136&#47;bjo.2008.151266</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.2008.151266</RefLink>
      </Reference>
      <Reference refNo="49">
        <RefAuthor>Tadayoni R</RefAuthor>
        <RefAuthor>Creuzot-Garcher C</RefAuthor>
        <RefAuthor>Korobelnik JF</RefAuthor>
        <RefAuthor>Le Mer Y</RefAuthor>
        <RefAuthor>Massin P</RefAuthor>
        <RefAuthor>Vicaut E</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefTitle>Internal limiting membrane peeling for large macular holes: a randomized, multicentric, and controlled clinical trial</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>5206</RefPage>
        <RefTotal>Tadayoni R, Creuzot-Garcher C, Korobelnik JF, Le Mer Y, Massin P, Vicaut E, Gaudric A. Internal limiting membrane peeling for large macular holes: a randomized, multicentric, and controlled clinical trial. Invest Ophthalmol Vis Sci. 2009 Apr;50(13):5206.</RefTotal>
      </Reference>
      <Reference refNo="50">
        <RefAuthor>Lois N</RefAuthor>
        <RefAuthor>Burr J</RefAuthor>
        <RefAuthor>Norrie J</RefAuthor>
        <RefAuthor>Vale L</RefAuthor>
        <RefAuthor>Cook J</RefAuthor>
        <RefAuthor>McDonald A</RefAuthor>
        <RefAuthor>Boachie C</RefAuthor>
        <RefAuthor>Ternent L</RefAuthor>
        <RefAuthor>McPherson G</RefAuthor>
        <RefAuthor> Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group</RefAuthor>
        <RefTitle>Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>1586-92</RefPage>
        <RefTotal>Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci. 2011 Mar;52(3):1586-92. DOI: 10.1167&#47;iovs.10-6287</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.10-6287</RefLink>
      </Reference>
      <Reference refNo="51">
        <RefAuthor>Kitao M</RefAuthor>
        <RefAuthor>Wakabayashi T</RefAuthor>
        <RefAuthor>Nishida K</RefAuthor>
        <RefAuthor>Sakaguchi H</RefAuthor>
        <RefAuthor>Nishida K</RefAuthor>
        <RefTitle>Long-term reconstruction of foveal microstructure and visual acuity after idiopathic macular hole repair: three-year follow-up study</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>238-44</RefPage>
        <RefTotal>Kitao M, Wakabayashi T, Nishida K, Sakaguchi H, Nishida K. Long-term reconstruction of foveal microstructure and visual acuity after idiopathic macular hole repair: three-year follow-up study. Br J Ophthalmol. 2019 Feb;103(2):238-44. DOI: 10.1136&#47;bjophthalmol-2017-311689</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjophthalmol-2017-311689</RefLink>
      </Reference>
      <Reference refNo="52">
        <RefAuthor>Bottoni F</RefAuthor>
        <RefAuthor>De Angelis S</RefAuthor>
        <RefAuthor>Luccarelli S</RefAuthor>
        <RefAuthor>Cigada M</RefAuthor>
        <RefAuthor>Staurenghi G</RefAuthor>
        <RefTitle>The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>4439-46</RefPage>
        <RefTotal>Bottoni F, De Angelis S, Luccarelli S, Cigada M, Staurenghi G. The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2011 Jun;52(7):4439-46. DOI: 10.1167&#47;iovs.10-6732</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.10-6732</RefLink>
      </Reference>
      <Reference refNo="53">
        <RefAuthor>Wakabayashi T</RefAuthor>
        <RefAuthor>Oshima Y</RefAuthor>
        <RefAuthor>Fujimoto H</RefAuthor>
        <RefAuthor>Murakami Y</RefAuthor>
        <RefAuthor>Sakaguchi H</RefAuthor>
        <RefAuthor>Kusaka S</RefAuthor>
        <RefAuthor>Tano Y</RefAuthor>
        <RefTitle>Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>519-28</RefPage>
        <RefTotal>Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology. 2009 Mar;116(3):519-28. DOI: 10.1016&#47;j.ophtha.2008.10.001</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2008.10.001</RefLink>
      </Reference>
      <Reference refNo="54">
        <RefAuthor>Mahmoud TH</RefAuthor>
        <RefAuthor>McCuen BW 2nd</RefAuthor>
        <RefTitle>Natural history of foveolar lucencies observed by optical coherence tomography after macular hole surgery</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>95-100</RefPage>
        <RefTotal>Mahmoud TH, McCuen BW 2nd. Natural history of foveolar lucencies observed by optical coherence tomography after macular hole surgery. Retina. 2007 Jan;27(1):95-100. DOI: 10.1097&#47;01.iae.0000223758.17543.49</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;01.iae.0000223758.17543.49</RefLink>
      </Reference>
      <Reference refNo="55">
        <RefAuthor>Tornambe PE</RefAuthor>
        <RefAuthor>Poliner LS</RefAuthor>
        <RefAuthor>Cohen RG</RefAuthor>
        <RefTitle>Definition of macular hole surgery end points: elevated&#47;open, flat&#47;open, flat&#47;closed</RefTitle>
        <RefYear>1998</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>286-7</RefPage>
        <RefTotal>Tornambe PE, Poliner LS, Cohen RG. Definition of macular hole surgery end points: elevated&#47;open, flat&#47;open, flat&#47;closed. Retina. 1998;18(3):286-7. DOI: 10.1097&#47;00006982-199803000-00021</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-199803000-00021</RefLink>
      </Reference>
      <Reference refNo="56">
        <RefAuthor>Imai M</RefAuthor>
        <RefAuthor>Iijima H</RefAuthor>
        <RefAuthor>Gotoh T</RefAuthor>
        <RefAuthor>Tsukahara S</RefAuthor>
        <RefTitle>Optical coherence tomography of successfully repaired idiopathic macular holes</RefTitle>
        <RefYear>1999</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>621-7</RefPage>
        <RefTotal>Imai M, Iijima H, Gotoh T, Tsukahara S. Optical coherence tomography of successfully repaired idiopathic macular holes. Am J Ophthalmol. 1999 Nov;128(5):621-7. DOI: 10.1016&#47;s0002-9394(99)00200-7</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(99)00200-7</RefLink>
      </Reference>
      <Reference refNo="57">
        <RefAuthor>Kang SW</RefAuthor>
        <RefAuthor>Ahn K</RefAuthor>
        <RefAuthor>Ham DI</RefAuthor>
        <RefTitle>Types of macular hole closure and their clinical implications</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1015-9</RefPage>
        <RefTotal>Kang SW, Ahn K, Ham DI. Types of macular hole closure and their clinical implications. Br J Ophthalmol. 2003 Aug;87(8):1015-9. DOI: 10.1136&#47;bjo.87.8.1015</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.87.8.1015</RefLink>
      </Reference>
      <Reference refNo="58">
        <RefAuthor>Rossi T</RefAuthor>
        <RefAuthor>Bacherini D</RefAuthor>
        <RefAuthor>Caporossi T</RefAuthor>
        <RefAuthor>Telani S</RefAuthor>
        <RefAuthor>Iannetta D</RefAuthor>
        <RefAuthor>Rizzo S</RefAuthor>
        <RefAuthor>Moysidis SN</RefAuthor>
        <RefAuthor>Koulisis N</RefAuthor>
        <RefAuthor>Mahmoud TH</RefAuthor>
        <RefAuthor>Ripandelli G</RefAuthor>
        <RefTitle>Macular hole closure patterns: an updated classification</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>2629-38</RefPage>
        <RefTotal>Rossi T, Bacherini D, Caporossi T, Telani S, Iannetta D, Rizzo S, Moysidis SN, Koulisis N, Mahmoud TH, Ripandelli G. Macular hole closure patterns: an updated classification. Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2629-38. DOI: 10.1007&#47;s00417-020-04920-4</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-020-04920-4</RefLink>
      </Reference>
      <Reference refNo="59">
        <RefAuthor>Da Mata AP</RefAuthor>
        <RefAuthor>Burk SE</RefAuthor>
        <RefAuthor>Foster RE</RefAuthor>
        <RefAuthor>Riemann CD</RefAuthor>
        <RefAuthor>Petersen MR</RefAuthor>
        <RefAuthor>Nehemy M&#225;</RefAuthor>
        <RefAuthor>Augsburger JJ</RefAuthor>
        <RefTitle>Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2246-53</RefPage>
        <RefTotal>Da Mata AP, Burk SE, Foster RE, Riemann CD, Petersen MR, Nehemy M&#225;, Augsburger JJ. Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair. Ophthalmology. 2004 Dec;111(12):2246-53. DOI: 10.1016&#47;j.ophtha.2004.05.037</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2004.05.037</RefLink>
      </Reference>
      <Reference refNo="60">
        <RefAuthor>Weinberger AW</RefAuthor>
        <RefAuthor>Schlossmacher B</RefAuthor>
        <RefAuthor>Dahlke C</RefAuthor>
        <RefAuthor>Hermel M</RefAuthor>
        <RefAuthor>Kirchhof B</RefAuthor>
        <RefAuthor>Schrage NF</RefAuthor>
        <RefTitle>Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery &#8211; a follow-up study</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>913-7</RefPage>
        <RefTotal>Weinberger AW, Schlossmacher B, Dahlke C, Hermel M, Kirchhof B, Schrage NF. Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery &#8211; a follow-up study. Graefes Arch Clin Exp Ophthalmol. 2002 Nov;240(11):913-7. DOI: 10.1007&#47;s00417-002-0544-1</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-002-0544-1</RefLink>
      </Reference>
      <Reference refNo="61">
        <RefAuthor>Lochhead J</RefAuthor>
        <RefAuthor>Jones E</RefAuthor>
        <RefAuthor>Chui D</RefAuthor>
        <RefAuthor>Lake S</RefAuthor>
        <RefAuthor>Karia N</RefAuthor>
        <RefAuthor>Patel CK</RefAuthor>
        <RefAuthor>Rosen P</RefAuthor>
        <RefTitle>Outcome of ICG-assisted ILM peel in macular hole surgery</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>804-8</RefPage>
        <RefTotal>Lochhead J, Jones E, Chui D, Lake S, Karia N, Patel CK, Rosen P. Outcome of ICG-assisted ILM peel in macular hole surgery. Eye (Lond). 2004 Aug;18(8):804-8. DOI: 10.1038&#47;sj.eye.6701328</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;sj.eye.6701328</RefLink>
      </Reference>
      <Reference refNo="62">
        <RefAuthor>Slaughter K</RefAuthor>
        <RefAuthor>Lee IL</RefAuthor>
        <RefTitle>Macular hole surgery with and without indocyanine green assistance</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>376-8</RefPage>
        <RefTotal>Slaughter K, Lee IL. Macular hole surgery with and without indocyanine green assistance. Eye (Lond). 2004 Apr;18(4):376-8. DOI: 10.1038&#47;sj.eye.6700666</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;sj.eye.6700666</RefLink>
      </Reference>
      <Reference refNo="63">
        <RefAuthor>Stanescu-Segall D</RefAuthor>
        <RefAuthor>Jackson TL</RefAuthor>
        <RefTitle>Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>504-18</RefPage>
        <RefTotal>Stanescu-Segall D, Jackson TL. Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye (Lond). 2009 Mar;23(3):504-18. DOI: 10.1038&#47;eye.2008.249</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;eye.2008.249</RefLink>
      </Reference>
      <Reference refNo="64">
        <RefAuthor>Tognetto D</RefAuthor>
        <RefAuthor>Grandin R</RefAuthor>
        <RefAuthor>Sanguinetti G</RefAuthor>
        <RefAuthor>Minutola D</RefAuthor>
        <RefAuthor>Di Nicola M</RefAuthor>
        <RefAuthor>Di Mascio R</RefAuthor>
        <RefAuthor>Ravalico G</RefAuthor>
        <RefAuthor> Macular Hole Surgery Study Group</RefAuthor>
        <RefTitle>Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1401-10</RefPage>
        <RefTotal>Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R, Ravalico G; Macular Hole Surgery Study Group. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology. 2006 Aug;113(8):1401-10. DOI: 10.1016&#47;j.ophtha.2006.02.061</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2006.02.061</RefLink>
      </Reference>
      <Reference refNo="65">
        <RefAuthor>Sheidow TG</RefAuthor>
        <RefAuthor>Blinder KJ</RefAuthor>
        <RefAuthor>Holekamp N</RefAuthor>
        <RefAuthor>Joseph D</RefAuthor>
        <RefAuthor>Shah G</RefAuthor>
        <RefAuthor>Grand MG</RefAuthor>
        <RefAuthor>Thomas MA</RefAuthor>
        <RefAuthor>Bakal J</RefAuthor>
        <RefAuthor>Sharma S</RefAuthor>
        <RefTitle>Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1697-701</RefPage>
        <RefTotal>Sheidow TG, Blinder KJ, Holekamp N, Joseph D, Shah G, Grand MG, Thomas MA, Bakal J, Sharma S. Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology. 2003 Sep;110(9):1697-701. DOI: 10.1016&#47;S0161-6420(03)00562-1</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;S0161-6420(03)00562-1</RefLink>
      </Reference>
      <Reference refNo="66">
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Schaumberger M</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>716-20</RefPage>
        <RefTotal>Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2003 Sep;241(9):716-20. DOI: 10.1007&#47;s00417-003-0710-0</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-003-0710-0</RefLink>
      </Reference>
      <Reference refNo="67">
        <RefAuthor>Ando F</RefAuthor>
        <RefAuthor>Sasano K</RefAuthor>
        <RefAuthor>Ohba N</RefAuthor>
        <RefAuthor>Hirose H</RefAuthor>
        <RefAuthor>Yasui O</RefAuthor>
        <RefTitle>Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>609-14</RefPage>
        <RefTotal>Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol. 2004 Apr;137(4):609-14. DOI: 10.1016&#47;j.ajo.2003.08.038</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2003.08.038</RefLink>
      </Reference>
      <Reference refNo="68">
        <RefAuthor>Enaida H</RefAuthor>
        <RefAuthor>Sakamoto T</RefAuthor>
        <RefAuthor>Hisatomi T</RefAuthor>
        <RefAuthor>Goto Y</RefAuthor>
        <RefAuthor>Ishibashi T</RefAuthor>
        <RefTitle>Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>209-13</RefPage>
        <RefTotal>Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol. 2002 Mar;240(3):209-13. DOI: 10.1007&#47;s00417-002-0433-7</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-002-0433-7</RefLink>
      </Reference>
      <Reference refNo="69">
        <RefAuthor>Maia M</RefAuthor>
        <RefAuthor>Margalit E</RefAuthor>
        <RefAuthor>Lakhanpal R</RefAuthor>
        <RefAuthor>Tso MO</RefAuthor>
        <RefAuthor>Grebe R</RefAuthor>
        <RefAuthor>Torres G</RefAuthor>
        <RefAuthor>Au Eong KG</RefAuthor>
        <RefAuthor>Farah ME</RefAuthor>
        <RefAuthor>Fujii GY</RefAuthor>
        <RefAuthor>Weiland J</RefAuthor>
        <RefAuthor>de Juan E Jr</RefAuthor>
        <RefAuthor>D&#8217;Anna SA</RefAuthor>
        <RefAuthor>Humayun MS</RefAuthor>
        <RefTitle>Effects of intravitreal indocyanine green injection in rabbits</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>69-79</RefPage>
        <RefTotal>Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, Au Eong KG, Farah ME, Fujii GY, Weiland J, de Juan E Jr, D&#8217;Anna SA, Humayun MS. Effects of intravitreal indocyanine green injection in rabbits. Retina. 2004 Feb;24(1):69-79. DOI: 10.1097&#47;00006982-200402000-00011</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200402000-00011</RefLink>
      </Reference>
      <Reference refNo="70">
        <RefAuthor>Czajka MP</RefAuthor>
        <RefAuthor>McCuen BW 2nd</RefAuthor>
        <RefAuthor>Cummings TJ</RefAuthor>
        <RefAuthor>Nguyen H</RefAuthor>
        <RefAuthor>Stinnett S</RefAuthor>
        <RefAuthor>Wong F</RefAuthor>
        <RefTitle>Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>275-82</RefPage>
        <RefTotal>Czajka MP, McCuen BW 2nd, Cummings TJ, Nguyen H, Stinnett S, Wong F. Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina. 2004 Apr;24(2):275-82. DOI: 10.1097&#47;00006982-200404000-00014</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200404000-00014</RefLink>
      </Reference>
      <Reference refNo="71">
        <RefAuthor>Sippy BD</RefAuthor>
        <RefAuthor>Engelbrecht NE</RefAuthor>
        <RefAuthor>Hubbard GB</RefAuthor>
        <RefAuthor>Moriarty SE</RefAuthor>
        <RefAuthor>Jiang S</RefAuthor>
        <RefAuthor>Aaberg TM Jr</RefAuthor>
        <RefAuthor>Aaberg TM Sr</RefAuthor>
        <RefAuthor>Grossniklaus HE</RefAuthor>
        <RefAuthor>Sternberg P Jr</RefAuthor>
        <RefTitle>Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>433-5</RefPage>
        <RefTotal>Sippy BD, Engelbrecht NE, Hubbard GB, Moriarty SE, Jiang S, Aaberg TM Jr, Aaberg TM Sr, Grossniklaus HE, Sternberg P Jr. Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol. 2001 Sep;132(3):433-5. DOI: 10.1016&#47;s0002-9394(01)01061-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(01)01061-3</RefLink>
      </Reference>
      <Reference refNo="72">
        <RefAuthor>Ho JD</RefAuthor>
        <RefAuthor>Tsai RJ</RefAuthor>
        <RefAuthor>Chen SN</RefAuthor>
        <RefAuthor>Chen HC</RefAuthor>
        <RefTitle>Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>1423-9</RefPage>
        <RefTotal>Ho JD, Tsai RJ, Chen SN, Chen HC. Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch Ophthalmol. 2003 Oct;121(10):1423-9. DOI: 10.1001&#47;archopht.121.10.1423</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.121.10.1423</RefLink>
      </Reference>
      <Reference refNo="73">
        <RefAuthor>Ikagawa H</RefAuthor>
        <RefAuthor>Yoneda M</RefAuthor>
        <RefAuthor>Iwaki M</RefAuthor>
        <RefAuthor>Isogai Z</RefAuthor>
        <RefAuthor>Tsujii K</RefAuthor>
        <RefAuthor>Yamazaki R</RefAuthor>
        <RefAuthor>Kamiya T</RefAuthor>
        <RefAuthor>Zako M</RefAuthor>
        <RefTitle>Chemical toxicity of indocyanine green damages retinal pigment epithelium</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>2531-9</RefPage>
        <RefTotal>Ikagawa H, Yoneda M, Iwaki M, Isogai Z, Tsujii K, Yamazaki R, Kamiya T, Zako M. Chemical toxicity of indocyanine green damages retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2531-9. DOI: 10.1167&#47;iovs.04-1521</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.04-1521</RefLink>
      </Reference>
      <Reference refNo="74">
        <RefAuthor>Iriyama A</RefAuthor>
        <RefAuthor>Uchida S</RefAuthor>
        <RefAuthor>Yanagi Y</RefAuthor>
        <RefAuthor>Tamaki Y</RefAuthor>
        <RefAuthor>Inoue Y</RefAuthor>
        <RefAuthor>Matsuura K</RefAuthor>
        <RefAuthor>Kadonosono K</RefAuthor>
        <RefAuthor>Araie M</RefAuthor>
        <RefTitle>Effects of indocyanine green on retinal ganglion cells</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>943-7</RefPage>
        <RefTotal>Iriyama A, Uchida S, Yanagi Y, Tamaki Y, Inoue Y, Matsuura K, Kadonosono K, Araie M. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):943-7. DOI: 10.1167&#47;iovs.03-1026</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.03-1026</RefLink>
      </Reference>
      <Reference refNo="75">
        <RefAuthor>Ciardella AP</RefAuthor>
        <RefAuthor>Schiff W</RefAuthor>
        <RefAuthor>Barile G</RefAuthor>
        <RefAuthor>Vidne O</RefAuthor>
        <RefAuthor>Sparrow J</RefAuthor>
        <RefAuthor>Langton K</RefAuthor>
        <RefAuthor>Chang S</RefAuthor>
        <RefTitle>Persistent indocyanine green fluorescence after vitrectomy for macular hole</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>174-7</RefPage>
        <RefTotal>Ciardella AP, Schiff W, Barile G, Vidne O, Sparrow J, Langton K, Chang S. Persistent indocyanine green fluorescence after vitrectomy for macular hole. Am J Ophthalmol. 2003 Jul;136(1):174-7. DOI: 10.1016&#47;s0002-9394(03)00090-4</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(03)00090-4</RefLink>
      </Reference>
      <Reference refNo="76">
        <RefAuthor>Tadayoni R</RefAuthor>
        <RefAuthor>Paques M</RefAuthor>
        <RefAuthor>Girmens JF</RefAuthor>
        <RefAuthor>Massin P</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefTitle>Persistence of fundus fluorescence after use of indocyanine green for macular surgery</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>604-8</RefPage>
        <RefTotal>Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A. Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology. 2003 Mar;110(3):604-8. DOI: 10.1016&#47;S0161-6420(02)01761-X</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;S0161-6420(02)01761-X</RefLink>
      </Reference>
      <Reference refNo="77">
        <RefAuthor>Nakamura H</RefAuthor>
        <RefAuthor>Hayakawa K</RefAuthor>
        <RefAuthor>Imaizumi A</RefAuthor>
        <RefAuthor>Sakai M</RefAuthor>
        <RefAuthor>Sawaguchi S</RefAuthor>
        <RefTitle>Persistence of retinal indocyanine green dye following vitreous surgery</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Ophthalmic Surg Lasers Imaging</RefJournal>
        <RefPage>37-45</RefPage>
        <RefTotal>Nakamura H, Hayakawa K, Imaizumi A, Sakai M, Sawaguchi S. Persistence of retinal indocyanine green dye following vitreous surgery. Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb;36(1):37-45.</RefTotal>
      </Reference>
      <Reference refNo="78">
        <RefAuthor>Paques M</RefAuthor>
        <RefAuthor>Genevois O</RefAuthor>
        <RefAuthor>R&#233;gnier A</RefAuthor>
        <RefAuthor>Tadayoni R</RefAuthor>
        <RefAuthor>Sercombe R</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefAuthor>Vicaut E</RefAuthor>
        <RefTitle>Axon-tracing properties of indocyanine green</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>367-70</RefPage>
        <RefTotal>Paques M, Genevois O, R&#233;gnier A, Tadayoni R, Sercombe R, Gaudric A, Vicaut E. Axon-tracing properties of indocyanine green. Arch Ophthalmol. 2003 Mar;121(3):367-70. DOI: 10.1001&#47;archopht.121.3.367</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.121.3.367</RefLink>
      </Reference>
      <Reference refNo="79">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Schaumberger M</RefAuthor>
        <RefAuthor>Ulbig MW</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>836-41</RefPage>
        <RefTotal>Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol. 2002 Dec;134(6):836-41. DOI: 10.1016&#47;s0002-9394(02)01816-0</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(02)01816-0</RefLink>
      </Reference>
      <Reference refNo="80">
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Ulbig MW</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>431-3</RefPage>
        <RefTotal>Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001 Sep;132(3):431-3. DOI: 10.1016&#47;s0002-9394(01)01087-x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(01)01087-x</RefLink>
      </Reference>
      <Reference refNo="81">
        <RefAuthor>Da Mata AP</RefAuthor>
        <RefAuthor>Burk SE</RefAuthor>
        <RefAuthor>Riemann CD</RefAuthor>
        <RefAuthor>Rosa RH Jr</RefAuthor>
        <RefAuthor>Snyder ME</RefAuthor>
        <RefAuthor>Petersen MR</RefAuthor>
        <RefAuthor>Foster RE</RefAuthor>
        <RefTitle>Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1187-92</RefPage>
        <RefTotal>Da Mata AP, Burk SE, Riemann CD, Rosa RH Jr, Snyder ME, Petersen MR, Foster RE. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology. 2001 Jul;108(7):1187-92. DOI: 10.1016&#47;s0161-6420(01)00593-0</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0161-6420(01)00593-0</RefLink>
      </Reference>
      <Reference refNo="82">
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefAuthor>Meyer CH</RefAuthor>
        <RefAuthor>Mennel S</RefAuthor>
        <RefAuthor>Farah ME</RefAuthor>
        <RefTitle>Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>958-70</RefPage>
        <RefTotal>Rodrigues EB, Meyer CH, Mennel S, Farah ME. Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina. 2007 Sep;27(7):958-70. DOI: 10.1097&#47;01.iae.0000253051.01194.ab</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;01.iae.0000253051.01194.ab</RefLink>
      </Reference>
      <Reference refNo="83">
        <RefAuthor>Grisanti S</RefAuthor>
        <RefAuthor>Altvater A</RefAuthor>
        <RefAuthor>Peters S</RefAuthor>
        <RefTitle>Safety parameters for indocyanine green in vitreoretinal surgery</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>Dev Ophthalmol</RefJournal>
        <RefPage>43-68</RefPage>
        <RefTotal>Grisanti S, Altvater A, Peters S. Safety parameters for indocyanine green in vitreoretinal surgery. Dev Ophthalmol. 2008;42:43-68. DOI: 10.1159&#47;000138924</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1159&#47;000138924</RefLink>
      </Reference>
      <Reference refNo="84">
        <RefAuthor>Jackson TL</RefAuthor>
        <RefAuthor>Vote B</RefAuthor>
        <RefAuthor>Knight BC</RefAuthor>
        <RefAuthor>El-Amir A</RefAuthor>
        <RefAuthor>Stanford MR</RefAuthor>
        <RefAuthor>Marshall J</RefAuthor>
        <RefTitle>Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>3697-703</RefPage>
        <RefTotal>Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3697-703. DOI: 10.1167&#47;iovs.04-0387</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.04-0387</RefLink>
      </Reference>
      <Reference refNo="85">
        <RefAuthor>Penha FM</RefAuthor>
        <RefAuthor>Maia M</RefAuthor>
        <RefAuthor>Farah ME</RefAuthor>
        <RefAuthor>Dib E</RefAuthor>
        <RefAuthor>Pr&#237;ncipe AH</RefAuthor>
        <RefAuthor>Devin F</RefAuthor>
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefAuthor>Duprat JP</RefAuthor>
        <RefAuthor>Freym&#252;ller E</RefAuthor>
        <RefTitle>Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>J Ocul Pharmacol Ther</RefJournal>
        <RefPage>52-61</RefPage>
        <RefTotal>Penha FM, Maia M, Farah ME, Dib E, Pr&#237;ncipe AH, Devin F, Rodrigues EB, Duprat JP, Freym&#252;ller E. Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits. J Ocul Pharmacol Ther. 2008 Feb;24(1):52-61. DOI: 10.1089&#47;jop.2007.0047</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1089&#47;jop.2007.0047</RefLink>
      </Reference>
      <Reference refNo="86">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5&#37; diluted indocyanine and infracyanine green</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>345-8</RefPage>
        <RefTotal>Haritoglou C, Gandorfer A, Gass CA, Kampik A. Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5&#37; diluted indocyanine and infracyanine green. Am J Ophthalmol. 2004 Feb;137(2):345-8. DOI: 10.1016&#47;S0002-9394(03)00845-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;S0002-9394(03)00845-6</RefLink>
      </Reference>
      <Reference refNo="87">
        <RefAuthor>La Heij EC</RefAuthor>
        <RefAuthor>Dieudonn&#233; SC</RefAuthor>
        <RefAuthor>Mooy CM</RefAuthor>
        <RefAuthor>Diederen RM</RefAuthor>
        <RefAuthor>Liem AT</RefAuthor>
        <RefAuthor>van Suylen RJ</RefAuthor>
        <RefAuthor>Hendrikse F</RefAuthor>
        <RefTitle>Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>1123-5</RefPage>
        <RefTotal>La Heij EC, Dieudonn&#233; SC, Mooy CM, Diederen RM, Liem AT, van Suylen RJ, Hendrikse F. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol. 2005 Dec;140(6):1123-5. DOI: 10.1016&#47;j.ajo.2005.05.054</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2005.05.054</RefLink>
      </Reference>
      <Reference refNo="88">
        <RefAuthor>Narayanan R</RefAuthor>
        <RefAuthor>Kenney MC</RefAuthor>
        <RefAuthor>Kamjoo S</RefAuthor>
        <RefAuthor>Trinh TH</RefAuthor>
        <RefAuthor>Seigel GM</RefAuthor>
        <RefAuthor>Resende GP</RefAuthor>
        <RefAuthor>Kuppermann BD</RefAuthor>
        <RefTitle>Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>304-9</RefPage>
        <RefTotal>Narayanan R, Kenney MC, Kamjoo S, Trinh TH, Seigel GM, Resende GP, Kuppermann BD. Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):304-9. DOI: 10.1167&#47;iovs.04-0703</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.04-0703</RefLink>
      </Reference>
      <Reference refNo="89">
        <RefAuthor>Kwok AK</RefAuthor>
        <RefAuthor>Yeung CK</RefAuthor>
        <RefAuthor>Lai TY</RefAuthor>
        <RefAuthor>Chan KP</RefAuthor>
        <RefAuthor>Pang CP</RefAuthor>
        <RefTitle>Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1590-4</RefPage>
        <RefTotal>Kwok AK, Yeung CK, Lai TY, Chan KP, Pang CP. Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells. Br J Ophthalmol. 2004 Dec;88(12):1590-4. DOI: 10.1136&#47;bjo.2004.044537</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.2004.044537</RefLink>
      </Reference>
      <Reference refNo="90">
        <RefAuthor>Kodjikian L</RefAuthor>
        <RefAuthor>Richter T</RefAuthor>
        <RefAuthor>Halberstadt M</RefAuthor>
        <RefAuthor>Beby F</RefAuthor>
        <RefAuthor>Flueckiger F</RefAuthor>
        <RefAuthor>Boehnke M</RefAuthor>
        <RefAuthor>Garweg JG</RefAuthor>
        <RefTitle>Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>917-25</RefPage>
        <RefTotal>Kodjikian L, Richter T, Halberstadt M, Beby F, Flueckiger F, Boehnke M, Garweg JG. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol. 2005 Sep;243(9):917-25. DOI: 10.1007&#47;s00417-004-1121-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-004-1121-6</RefLink>
      </Reference>
      <Reference refNo="91">
        <RefAuthor>Gale JS</RefAuthor>
        <RefAuthor>Proulx AA</RefAuthor>
        <RefAuthor>Gonder JR</RefAuthor>
        <RefAuthor>Mao AJ</RefAuthor>
        <RefAuthor>Hutnik CM</RefAuthor>
        <RefTitle>Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>64-9</RefPage>
        <RefTotal>Gale JS, Proulx AA, Gonder JR, Mao AJ, Hutnik CM. Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol. 2004 Jul;138(1):64-9. DOI: 10.1016&#47;j.ajo.2004.02.061</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2004.02.061</RefLink>
      </Reference>
      <Reference refNo="92">
        <RefAuthor>Mennel S</RefAuthor>
        <RefAuthor>Thumann G</RefAuthor>
        <RefAuthor>Peter S</RefAuthor>
        <RefAuthor>Meyer CH</RefAuthor>
        <RefAuthor>Kroll P</RefAuthor>
        <RefTitle>Einfluss von Vitalfarbstoffen auf die Funktion der &#228;usseren Blut-Retina-Schranke in vitro</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Klin Monbl Augenheilkd</RefJournal>
        <RefPage>568-76</RefPage>
        <RefTotal>Mennel S, Thumann G, Peter S, Meyer CH, Kroll P. Einfluss von Vitalfarbstoffen auf die Funktion der &#228;usseren Blut-Retina-Schranke in vitro &#91;Influence of vital dyes on the function of the outer blood-retinal barrier in vitro&#93;. Klin Monbl Augenheilkd. 2006 Jul;223(7):568-76. DOI: 10.1055&#47;s-2006-926479</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1055&#47;s-2006-926479</RefLink>
      </Reference>
      <Reference refNo="93">
        <RefAuthor>Jin Y</RefAuthor>
        <RefAuthor>Uchida S</RefAuthor>
        <RefAuthor>Yanagi Y</RefAuthor>
        <RefAuthor>Aihara M</RefAuthor>
        <RefAuthor>Araie M</RefAuthor>
        <RefTitle>Neurotoxic effects of trypan blue on rat retinal ganglion cells</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Exp Eye Res</RefJournal>
        <RefPage>395-400</RefPage>
        <RefTotal>Jin Y, Uchida S, Yanagi Y, Aihara M, Araie M. Neurotoxic effects of trypan blue on rat retinal ganglion cells. Exp Eye Res. 2005 Oct;81(4):395-400. DOI: 10.1016&#47;j.exer.2005.02.010</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.exer.2005.02.010</RefLink>
      </Reference>
      <Reference refNo="94">
        <RefAuthor>Farah ME</RefAuthor>
        <RefAuthor>Maia M</RefAuthor>
        <RefAuthor>Furlani B</RefAuthor>
        <RefAuthor>Bott&#243;s J</RefAuthor>
        <RefAuthor>Meyer CH</RefAuthor>
        <RefAuthor>Lima V</RefAuthor>
        <RefAuthor>Penha FM</RefAuthor>
        <RefAuthor>Costa EF</RefAuthor>
        <RefAuthor>Rodrigues EB</RefAuthor>
        <RefTitle>Current concepts of trypan blue in chromovitrectomy</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>Dev Ophthalmol</RefJournal>
        <RefPage>91-100</RefPage>
        <RefTotal>Farah ME, Maia M, Furlani B, Bott&#243;s J, Meyer CH, Lima V, Penha FM, Costa EF, Rodrigues EB. Current concepts of trypan blue in chromovitrectomy. Dev Ophthalmol. 2008;42:91-100. DOI: 10.1159&#47;000138980</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1159&#47;000138980</RefLink>
      </Reference>
      <Reference refNo="95">
        <RefAuthor>Lee KL</RefAuthor>
        <RefAuthor>Dean S</RefAuthor>
        <RefAuthor>Guest S</RefAuthor>
        <RefTitle>A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>420-4</RefPage>
        <RefTotal>Lee KL, Dean S, Guest S. A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery. Br J Ophthalmol. 2005 Apr;89(4):420-4. DOI: 10.1136&#47;bjo.2004.049684</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjo.2004.049684</RefLink>
      </Reference>
      <Reference refNo="96">
        <RefAuthor>Beutel J</RefAuthor>
        <RefAuthor>Dahmen G</RefAuthor>
        <RefAuthor>Ziegler A</RefAuthor>
        <RefAuthor>Hoerauf H</RefAuthor>
        <RefTitle>Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>326-32</RefPage>
        <RefTotal>Beutel J, Dahmen G, Ziegler A, Hoerauf H. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol. 2007 Mar;125(3):326-32. DOI: 10.1001&#47;archopht.125.3.326</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.125.3.326</RefLink>
      </Reference>
      <Reference refNo="97">
        <RefAuthor>Shukla D</RefAuthor>
        <RefAuthor>Kalliath J</RefAuthor>
        <RefAuthor>Neelakantan N</RefAuthor>
        <RefAuthor>Naresh KB</RefAuthor>
        <RefAuthor>Ramasamy K</RefAuthor>
        <RefTitle>A comparison of brilliant blue G, trypan blue, and indocyanine green dyes to assist internal limiting membrane peeling during macular hole surgery</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>2021-5</RefPage>
        <RefTotal>Shukla D, Kalliath J, Neelakantan N, Naresh KB, Ramasamy K. A comparison of brilliant blue G, trypan blue, and indocyanine green dyes to assist internal limiting membrane peeling during macular hole surgery. Retina. 2011 Nov;31(10):2021-5. DOI: 10.1097&#47;IAE.0b013e318213618c</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0b013e318213618c</RefLink>
      </Reference>
      <Reference refNo="98">
        <RefAuthor>Bellerive C</RefAuthor>
        <RefAuthor>Cinq-Mars B</RefAuthor>
        <RefAuthor>Louis M</RefAuthor>
        <RefAuthor>Tardif Y</RefAuthor>
        <RefAuthor>Giasson M</RefAuthor>
        <RefAuthor>Francis K</RefAuthor>
        <RefAuthor>H&#233;bert M</RefAuthor>
        <RefTitle>Retinal function assessment of trypan blue versus indocyanine green assisted internal limiting membrane peeling during macular hole surgery</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Can J Ophthalmol</RefJournal>
        <RefPage>104-9</RefPage>
        <RefTotal>Bellerive C, Cinq-Mars B, Louis M, Tardif Y, Giasson M, Francis K, H&#233;bert M. Retinal function assessment of trypan blue versus indocyanine green assisted internal limiting membrane peeling during macular hole surgery. Can J Ophthalmol. 2013 Apr;48(2):104-9. DOI: 10.1016&#47;j.jcjo.2012.10.009</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jcjo.2012.10.009</RefLink>
      </Reference>
      <Reference refNo="99">
        <RefAuthor>Lesnik Oberstein SY</RefAuthor>
        <RefAuthor>de Smet MD</RefAuthor>
        <RefTitle>Use of heavy Trypan blue in macular hole surgery</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>1177-81</RefPage>
        <RefTotal>Lesnik Oberstein SY, de Smet MD. Use of heavy Trypan blue in macular hole surgery. Eye (Lond). 2010 Jul;24(7):1177-81. DOI: 10.1038&#47;eye.2010.3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;eye.2010.3</RefLink>
      </Reference>
      <Reference refNo="100">
        <RefAuthor>Hisatomi T</RefAuthor>
        <RefAuthor>Enaida H</RefAuthor>
        <RefAuthor>Matsumoto H</RefAuthor>
        <RefAuthor>Kagimoto T</RefAuthor>
        <RefAuthor>Ueno A</RefAuthor>
        <RefAuthor>Hata Y</RefAuthor>
        <RefAuthor>Kubota T</RefAuthor>
        <RefAuthor>Goto Y</RefAuthor>
        <RefAuthor>Ishibashi T</RefAuthor>
        <RefTitle>Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Arch Ophthalmol</RefJournal>
        <RefPage>514-9</RefPage>
        <RefTotal>Hisatomi T, Enaida H, Matsumoto H, Kagimoto T, Ueno A, Hata Y, Kubota T, Goto Y, Ishibashi T. Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining. Arch Ophthalmol. 2006 Apr;124(4):514-9. DOI: 10.1001&#47;archopht.124.4.514</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;archopht.124.4.514</RefLink>
      </Reference>
      <Reference refNo="101">
        <RefAuthor>Enaida H</RefAuthor>
        <RefAuthor>Hisatomi T</RefAuthor>
        <RefAuthor>Goto Y</RefAuthor>
        <RefAuthor>Hata Y</RefAuthor>
        <RefAuthor>Ueno A</RefAuthor>
        <RefAuthor>Miura M</RefAuthor>
        <RefAuthor>Kubota T</RefAuthor>
        <RefAuthor>Ishibashi T</RefAuthor>
        <RefTitle>Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>623-30</RefPage>
        <RefTotal>Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T. Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina. 2006 Jul-Aug;26(6):623-30. DOI: 10.1097&#47;01.iae.0000236470.71443.7c</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;01.iae.0000236470.71443.7c</RefLink>
      </Reference>
      <Reference refNo="102">
        <RefAuthor>Azuma K</RefAuthor>
        <RefAuthor>Noda Y</RefAuthor>
        <RefAuthor>Hirasawa K</RefAuthor>
        <RefAuthor>Ueta T</RefAuthor>
        <RefTitle>Brilliant Blue G-Assisted Internal Limiting Membrane Peeling for Macular Hole: A Systematic Review of Literature and Meta-Analysis</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>851-8</RefPage>
        <RefTotal>Azuma K, Noda Y, Hirasawa K, Ueta T. Brilliant Blue G-Assisted Internal Limiting Membrane Peeling for Macular Hole: A Systematic Review of Literature and Meta-Analysis. Retina. 2016 May;36(5):851-8. DOI: 10.1097&#47;IAE.0000000000000968</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000968</RefLink>
      </Reference>
      <Reference refNo="103">
        <RefAuthor>Wang XW</RefAuthor>
        <RefAuthor>Long Y</RefAuthor>
        <RefAuthor>Gu YS</RefAuthor>
        <RefAuthor>Guo DY</RefAuthor>
        <RefTitle>Outcomes of 4 surgical adjuvants used for internal limiting membrane peeling in macular hole surgery: a systematic review and network Meta-analysis</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Int J Ophthalmol</RefJournal>
        <RefPage>481-7</RefPage>
        <RefTotal>Wang XW, Long Y, Gu YS, Guo DY. Outcomes of 4 surgical adjuvants used for internal limiting membrane peeling in macular hole surgery: a systematic review and network Meta-analysis. Int J Ophthalmol. 2020;13(3):481-7. DOI: 10.18240&#47;ijo.2020.03.17</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.18240&#47;ijo.2020.03.17</RefLink>
      </Reference>
      <Reference refNo="104">
        <RefAuthor>Koto T</RefAuthor>
        <RefAuthor>Inoue M</RefAuthor>
        <RefAuthor>Shinoda K</RefAuthor>
        <RefAuthor>Ishida S</RefAuthor>
        <RefAuthor>Tsubota K</RefAuthor>
        <RefTitle>Residual crystals of triamcinolone acetonide in macular hole may prevent complete closure</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Acta Ophthalmol Scand</RefJournal>
        <RefPage>913-4</RefPage>
        <RefTotal>Koto T, Inoue M, Shinoda K, Ishida S, Tsubota K. Residual crystals of triamcinolone acetonide in macular hole may prevent complete closure. Acta Ophthalmol Scand. 2007 Dec;85(8):913-4. DOI: 10.1111&#47;j.1600-0420.2007.00965.x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;j.1600-0420.2007.00965.x</RefLink>
      </Reference>
      <Reference refNo="105">
        <RefAuthor>Yamauchi Y</RefAuthor>
        <RefAuthor>Nakamura H</RefAuthor>
        <RefAuthor>Hayakawa K</RefAuthor>
        <RefAuthor>Sawaguchi S</RefAuthor>
        <RefTitle>Persistence of triamcinolone acetonide following macular hole surgery</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Acta Ophthalmol Scand</RefJournal>
        <RefPage>711-2</RefPage>
        <RefTotal>Yamauchi Y, Nakamura H, Hayakawa K, Sawaguchi S. Persistence of triamcinolone acetonide following macular hole surgery. Acta Ophthalmol Scand. 2006 Oct;84(5):711-2. DOI: 10.1111&#47;j.1600-0420.2006.00702.x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;j.1600-0420.2006.00702.x</RefLink>
      </Reference>
      <Reference refNo="106">
        <RefAuthor>Fukukita M</RefAuthor>
        <RefAuthor>Sasoh M</RefAuthor>
        <RefAuthor>Matsubara H</RefAuthor>
        <RefAuthor>Furuta M</RefAuthor>
        <RefAuthor>Okawa C</RefAuthor>
        <RefAuthor>Ito Y</RefAuthor>
        <RefAuthor>Wakitani Y</RefAuthor>
        <RefAuthor>Uji Y</RefAuthor>
        <RefTitle>Triamcinolone acetonide remaining on the fovea after successful macular hole closure</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>122-3</RefPage>
        <RefTotal>Fukukita M, Sasoh M, Matsubara H, Furuta M, Okawa C, Ito Y, Wakitani Y, Uji Y. Triamcinolone acetonide remaining on the fovea after successful macular hole closure. Retina. 2007 Jan;27(1):122-3. DOI: 10.1097&#47;01.iae.0000258270.98012.62</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;01.iae.0000258270.98012.62</RefLink>
      </Reference>
      <Reference refNo="107">
        <RefAuthor>Kumar A</RefAuthor>
        <RefAuthor>Sinha S</RefAuthor>
        <RefAuthor>Gupta A</RefAuthor>
        <RefTitle>Residual triamcinolone acetonide at macular hole after vitreous surgery</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Indian J Ophthalmol</RefJournal>
        <RefPage>232-4</RefPage>
        <RefTotal>Kumar A, Sinha S, Gupta A. Residual triamcinolone acetonide at macular hole after vitreous surgery. Indian J Ophthalmol. 2010 May-Jun;58(3):232-4. DOI: 10.4103&#47;0301-4738.62650</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;0301-4738.62650</RefLink>
      </Reference>
      <Reference refNo="108">
        <RefAuthor>Yu SY</RefAuthor>
        <RefAuthor>Damico FM</RefAuthor>
        <RefAuthor>Viola F</RefAuthor>
        <RefAuthor>D&#8217;Amico DJ</RefAuthor>
        <RefAuthor>Young LH</RefAuthor>
        <RefTitle>Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>531-6</RefPage>
        <RefTotal>Yu SY, Damico FM, Viola F, D&#8217;Amico DJ, Young LH. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina. 2006 May-Jun;26(5):531-6. DOI: 10.1097&#47;00006982-200605000-00006</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200605000-00006</RefLink>
      </Reference>
      <Reference refNo="109">
        <RefAuthor>Kim H</RefAuthor>
        <RefAuthor>Csaky KG</RefAuthor>
        <RefAuthor>Gravlin L</RefAuthor>
        <RefAuthor>Yuan P</RefAuthor>
        <RefAuthor>Lutz RJ</RefAuthor>
        <RefAuthor>Bungay PM</RefAuthor>
        <RefAuthor>Tansey G</RefAuthor>
        <RefAuthor>De Monasterio F</RefAuthor>
        <RefAuthor>Potti GK</RefAuthor>
        <RefAuthor>Grimes G</RefAuthor>
        <RefAuthor>Robinson MR</RefAuthor>
        <RefTitle>Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>523-30</RefPage>
        <RefTotal>Kim H, Csaky KG, Gravlin L, Yuan P, Lutz RJ, Bungay PM, Tansey G, De Monasterio F, Potti GK, Grimes G, Robinson MR. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina. 2006 May-Jun;26(5):523-30. DOI: 10.1097&#47;00006982-200605000-00005</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200605000-00005</RefLink>
      </Reference>
      <Reference refNo="110">
        <RefAuthor>Ye YF</RefAuthor>
        <RefAuthor>Gao YF</RefAuthor>
        <RefAuthor>Xie HT</RefAuthor>
        <RefAuthor>Wang HJ</RefAuthor>
        <RefTitle>Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Mol Vis</RefJournal>
        <RefPage>629-36</RefPage>
        <RefTotal>Ye YF, Gao YF, Xie HT, Wang HJ. Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits. Mol Vis. 2014 May 13;20:629-36.</RefTotal>
      </Reference>
      <Reference refNo="111">
        <RefAuthor>El Tarshouby S</RefAuthor>
        <RefAuthor>El-Hefney E</RefAuthor>
        <RefAuthor>Abd El Ghany A</RefAuthor>
        <RefTitle>Retinal toxicity of intravitreal triamcinolone acetonide &#8211; A histopathological study</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Researchgate</RefJournal>
        <RefPage></RefPage>
        <RefTotal>El Tarshouby S, El-Hefney E, Abd El Ghany A. Retinal toxicity of intravitreal triamcinolone acetonide &#8211; A histopathological study. Researchgate. 2019 Jul. Available from: https:&#47;&#47;www.researchgate.net&#47;publication&#47;334508611</RefTotal>
        <RefLink>https:&#47;&#47;www.researchgate.net&#47;publication&#47;334508611</RefLink>
      </Reference>
      <Reference refNo="112">
        <RefAuthor>Clark A</RefAuthor>
        <RefAuthor>Balducci N</RefAuthor>
        <RefAuthor>Pichi F</RefAuthor>
        <RefAuthor>Veronese C</RefAuthor>
        <RefAuthor>Morara M</RefAuthor>
        <RefAuthor>Torrazza C</RefAuthor>
        <RefAuthor>Ciardella AP</RefAuthor>
        <RefTitle>Swelling of the arcuate nerve fiber layer after internal limiting membrane peeling</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1608-13</RefPage>
        <RefTotal>Clark A, Balducci N, Pichi F, Veronese C, Morara M, Torrazza C, Ciardella AP. Swelling of the arcuate nerve fiber layer after internal limiting membrane peeling. Retina. 2012 Sep;32(8):1608-13. DOI: 10.1097&#47;IAE.0b013e3182437e86</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0b013e3182437e86</RefLink>
      </Reference>
      <Reference refNo="113">
        <RefAuthor>Tadayoni R</RefAuthor>
        <RefAuthor>Paques M</RefAuthor>
        <RefAuthor>Massin P</RefAuthor>
        <RefAuthor>Mouki-Benani S</RefAuthor>
        <RefAuthor>Mikol J</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefTitle>Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2279-83</RefPage>
        <RefTotal>Tadayoni R, Paques M, Massin P, Mouki-Benani S, Mikol J, Gaudric A. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology. 2001 Dec;108(12):2279-83. DOI: 10.1016&#47;s0161-6420(01)00856-9</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0161-6420(01)00856-9</RefLink>
      </Reference>
      <Reference refNo="114">
        <RefAuthor>Miura M</RefAuthor>
        <RefAuthor>Elsner AE</RefAuthor>
        <RefAuthor>Osako M</RefAuthor>
        <RefAuthor>Iwasaki T</RefAuthor>
        <RefAuthor>Okano T</RefAuthor>
        <RefAuthor>Usui M</RefAuthor>
        <RefTitle>Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>561-3</RefPage>
        <RefTotal>Miura M, Elsner AE, Osako M, Iwasaki T, Okano T, Usui M. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole. Retina. 2003 Aug;23(4):561-3. DOI: 10.1097&#47;00006982-200308000-00024</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200308000-00024</RefLink>
      </Reference>
      <Reference refNo="115">
        <RefAuthor>Ito Y</RefAuthor>
        <RefAuthor>Terasaki H</RefAuthor>
        <RefAuthor>Takahashi A</RefAuthor>
        <RefAuthor>Yamakoshi T</RefAuthor>
        <RefAuthor>Kondo M</RefAuthor>
        <RefAuthor>Nakamura M</RefAuthor>
        <RefTitle>Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular holes</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1415-20</RefPage>
        <RefTotal>Ito Y, Terasaki H, Takahashi A, Yamakoshi T, Kondo M, Nakamura M. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular holes. Ophthalmology. 2005 Aug;112(8):1415-20. DOI: 10.1016&#47;j.ophtha.2005.02.023</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2005.02.023</RefLink>
      </Reference>
      <Reference refNo="116">
        <RefAuthor>Mitamura Y</RefAuthor>
        <RefAuthor>Suzuki T</RefAuthor>
        <RefAuthor>Kinoshita T</RefAuthor>
        <RefAuthor>Miyano N</RefAuthor>
        <RefAuthor>Tashimo A</RefAuthor>
        <RefAuthor>Ohtsuka K</RefAuthor>
        <RefTitle>Optical coherence tomographic findings of dissociated optic nerve fiber layer appearance</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>1155-6</RefPage>
        <RefTotal>Mitamura Y, Suzuki T, Kinoshita T, Miyano N, Tashimo A, Ohtsuka K. Optical coherence tomographic findings of dissociated optic nerve fiber layer appearance. Am J Ophthalmol. 2004 Jun;137(6):1155-6. DOI: 10.1016&#47;j.ajo.2004.01.052</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2004.01.052</RefLink>
      </Reference>
      <Reference refNo="117">
        <RefAuthor>Nukada K</RefAuthor>
        <RefAuthor>Hangai M</RefAuthor>
        <RefAuthor>Ooto S</RefAuthor>
        <RefAuthor>Yoshikawa M</RefAuthor>
        <RefAuthor>Yoshimura N</RefAuthor>
        <RefTitle>Tomographic features of macula after successful macular hole surgery</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>2417-28</RefPage>
        <RefTotal>Nukada K, Hangai M, Ooto S, Yoshikawa M, Yoshimura N. Tomographic features of macula after successful macular hole surgery. Invest Ophthalmol Vis Sci. 2013 Apr;54(4):2417-28. DOI: 10.1167&#47;iovs.12-10838</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.12-10838</RefLink>
      </Reference>
      <Reference refNo="118">
        <RefAuthor>Alkabes M</RefAuthor>
        <RefAuthor>Salinas C</RefAuthor>
        <RefAuthor>Vitale L</RefAuthor>
        <RefAuthor>Bur&#233;s-Jelstrup A</RefAuthor>
        <RefAuthor>Nucci P</RefAuthor>
        <RefAuthor>Mateo C</RefAuthor>
        <RefTitle>En face optical coherence tomography of inner retinal defects after internal limiting membrane peeling for idiopathic macular hole</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>8349-55</RefPage>
        <RefTotal>Alkabes M, Salinas C, Vitale L, Bur&#233;s-Jelstrup A, Nucci P, Mateo C. En face optical coherence tomography of inner retinal defects after internal limiting membrane peeling for idiopathic macular hole. Invest Ophthalmol Vis Sci. 2011 Oct;52(11):8349-55. DOI: 10.1167&#47;iovs.11-8043</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.11-8043</RefLink>
      </Reference>
      <Reference refNo="119">
        <RefAuthor>Liu J</RefAuthor>
        <RefAuthor>Chen Y</RefAuthor>
        <RefAuthor>Wang S</RefAuthor>
        <RefAuthor>Zhang X</RefAuthor>
        <RefAuthor>Zhao P</RefAuthor>
        <RefTitle>Evaluating inner retinal dimples after inner limiting membrane removal using multimodal imaging of optical coherence tomography</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>BMC Ophthalmol</RefJournal>
        <RefPage>155</RefPage>
        <RefTotal>Liu J, Chen Y, Wang S, Zhang X, Zhao P. Evaluating inner retinal dimples after inner limiting membrane removal using multimodal imaging of optical coherence tomography. BMC Ophthalmol. 2018 Jun;18(1):155. DOI: 10.1186&#47;s12886-018-0828-9</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12886-018-0828-9</RefLink>
      </Reference>
      <Reference refNo="120">
        <RefAuthor>Navajas EV</RefAuthor>
        <RefAuthor>Schuck N</RefAuthor>
        <RefAuthor>Govetto A</RefAuthor>
        <RefAuthor>Akil H</RefAuthor>
        <RefAuthor>Docherty G</RefAuthor>
        <RefAuthor>Heisler M</RefAuthor>
        <RefAuthor>Sarunic MV</RefAuthor>
        <RefAuthor>Sarraf D</RefAuthor>
        <RefTitle>En face optical coherence tomography and optical coherence tomography angiography of inner retinal dimples after internal limiting membrane peeling for full-thickness macular holes</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>557-66</RefPage>
        <RefTotal>Navajas EV, Schuck N, Govetto A, Akil H, Docherty G, Heisler M, Sarunic MV, Sarraf D. En face optical coherence tomography and optical coherence tomography angiography of inner retinal dimples after internal limiting membrane peeling for full-thickness macular holes. Retina. 2020 Mar;40(3):557-66. DOI: 10.1097&#47;IAE.0000000000002432</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000002432</RefLink>
      </Reference>
      <Reference refNo="121">
        <RefAuthor>Spaide RF</RefAuthor>
        <RefTitle>&#8220;Dissociated optic nerve fiber layer appearance&#8221; after internal limiting membrane removal is inner retinal dimpling</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1719-26</RefPage>
        <RefTotal>Spaide RF. &#8220;Dissociated optic nerve fiber layer appearance&#8221; after internal limiting membrane removal is inner retinal dimpling. Retina. 2012 Oct;32(9):1719-26. DOI: 10.1097&#47;IAE.0b013e3182671191</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0b013e3182671191</RefLink>
      </Reference>
      <Reference refNo="122">
        <RefAuthor>Nakamura T</RefAuthor>
        <RefAuthor>Murata T</RefAuthor>
        <RefAuthor>Hisatomi T</RefAuthor>
        <RefAuthor>Enaida H</RefAuthor>
        <RefAuthor>Sassa Y</RefAuthor>
        <RefAuthor>Ueno A</RefAuthor>
        <RefAuthor>Sakamoto T</RefAuthor>
        <RefAuthor>Ishibashi T</RefAuthor>
        <RefTitle>Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Curr Eye Res</RefJournal>
        <RefPage>395-9</RefPage>
        <RefTotal>Nakamura T, Murata T, Hisatomi T, Enaida H, Sassa Y, Ueno A, Sakamoto T, Ishibashi T. Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green. Curr Eye Res. 2003 Dec;27(6):395-9. DOI: 10.1076&#47;ceyr.27.6.395.18189</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1076&#47;ceyr.27.6.395.18189</RefLink>
      </Reference>
      <Reference refNo="123">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>NFL appearance after peeling</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>1690</RefPage>
        <RefTotal>Haritoglou C, Gandorfer A, Kampik A. NFL appearance after peeling. Ophthalmology. 2006 Sep;113(9):1690. DOI: 10.1016&#47;j.ophtha.2006.01.020</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2006.01.020</RefLink>
      </Reference>
      <Reference refNo="124">
        <RefAuthor>Runkle AP</RefAuthor>
        <RefAuthor>Srivastava SK</RefAuthor>
        <RefAuthor>Yuan A</RefAuthor>
        <RefAuthor>Kaiser PK</RefAuthor>
        <RefAuthor>Singh RP</RefAuthor>
        <RefAuthor>Reese JL</RefAuthor>
        <RefAuthor>Ehlers JP</RefAuthor>
        <RefTitle>Factors associated with development of dissociated optic nerve fiber layer appearance in the pioneer intraoperative optical coherence tomography study</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>S103-S109</RefPage>
        <RefTotal>Runkle AP, Srivastava SK, Yuan A, Kaiser PK, Singh RP, Reese JL, Ehlers JP. Factors associated with development of dissociated optic nerve fiber layer appearance in the pioneer intraoperative optical coherence tomography study. Retina. 2018 Sep;38 Suppl 1:S103-S109. DOI: 10.1097&#47;IAE.0000000000002017</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000002017</RefLink>
      </Reference>
      <Reference refNo="125">
        <RefAuthor>Terasaki H</RefAuthor>
        <RefAuthor>Miyake Y</RefAuthor>
        <RefAuthor>Nomura R</RefAuthor>
        <RefAuthor>Piao CH</RefAuthor>
        <RefAuthor>Hori K</RefAuthor>
        <RefAuthor>Niwa T</RefAuthor>
        <RefAuthor>Kondo M</RefAuthor>
        <RefTitle>Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>229-34</RefPage>
        <RefTotal>Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T, Kondo M. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):229-34.</RefTotal>
      </Reference>
      <Reference refNo="126">
        <RefAuthor>Steel DH</RefAuthor>
        <RefAuthor>Dinah C</RefAuthor>
        <RefAuthor>White K</RefAuthor>
        <RefAuthor>Avery PJ</RefAuthor>
        <RefTitle>The relationship between a dissociated optic nerve fibre layer appearance after macular hole surgery and Muller cell debris on peeled internal limiting membrane</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Acta Ophthalmol</RefJournal>
        <RefPage>153-7</RefPage>
        <RefTotal>Steel DH, Dinah C, White K, Avery PJ. The relationship between a dissociated optic nerve fibre layer appearance after macular hole surgery and Muller cell debris on peeled internal limiting membrane. Acta Ophthalmol. 2017 Mar;95(2):153-7. DOI: 10.1111&#47;aos.13195</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;aos.13195</RefLink>
      </Reference>
      <Reference refNo="127">
        <RefAuthor>Steel DH</RefAuthor>
        <RefAuthor>Dinah C</RefAuthor>
        <RefAuthor>Habib M</RefAuthor>
        <RefAuthor>White K</RefAuthor>
        <RefTitle>ILM peeling technique influences the degree of a dissociated optic nerve fibre layer appearance after macular hole surgery</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Graefes Arch Clin Exp Ophthalmol</RefJournal>
        <RefPage>691-8</RefPage>
        <RefTotal>Steel DH, Dinah C, Habib M, White K. ILM peeling technique influences the degree of a dissociated optic nerve fibre layer appearance after macular hole surgery. Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):691-8. DOI: 10.1007&#47;s00417-014-2734-z</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00417-014-2734-z</RefLink>
      </Reference>
      <Reference refNo="128">
        <RefAuthor>Balducci N</RefAuthor>
        <RefAuthor>Morara M</RefAuthor>
        <RefAuthor>Veronese C</RefAuthor>
        <RefAuthor>Torrazza C</RefAuthor>
        <RefAuthor>Pichi F</RefAuthor>
        <RefAuthor>Ciardella AP</RefAuthor>
        <RefTitle>Retinal nerve fiber layer thickness modification after internal limiting membrane peeling</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>655-63</RefPage>
        <RefTotal>Balducci N, Morara M, Veronese C, Torrazza C, Pichi F, Ciardella AP. Retinal nerve fiber layer thickness modification after internal limiting membrane peeling. Retina. 2014 Apr;34(4):655-63. DOI: 10.1097&#47;IAE.0000000000000004</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000004</RefLink>
      </Reference>
      <Reference refNo="129">
        <RefAuthor>Ohta K</RefAuthor>
        <RefAuthor>Sato A</RefAuthor>
        <RefAuthor>Senda N</RefAuthor>
        <RefAuthor>Fukui E</RefAuthor>
        <RefTitle>Transient Increase of Retinal Nerve Fiber Layer Thickness after Vitrectomy with ILM Peeling for Idiopathic Macular Hole</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>5903452</RefPage>
        <RefTotal>Ohta K, Sato A, Senda N, Fukui E. Transient Increase of Retinal Nerve Fiber Layer Thickness after Vitrectomy with ILM Peeling for Idiopathic Macular Hole. J Ophthalmol. 2016;2016:5903452. DOI: 10.1155&#47;2016&#47;5903452</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2016&#47;5903452</RefLink>
      </Reference>
      <Reference refNo="130">
        <RefAuthor>Toba Y</RefAuthor>
        <RefAuthor>Machida S</RefAuthor>
        <RefAuthor>Kurosaka D</RefAuthor>
        <RefTitle>Comparisons of retinal nerve fiber layer thickness after indocyanine green, brilliant blue g, or triamcinolone acetonide-assisted macular hole surgery</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>187308</RefPage>
        <RefTotal>Toba Y, Machida S, Kurosaka D. Comparisons of retinal nerve fiber layer thickness after indocyanine green, brilliant blue g, or triamcinolone acetonide-assisted macular hole surgery. J Ophthalmol. 2014;2014:187308. DOI: 10.1155&#47;2014&#47;187308</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2014&#47;187308</RefLink>
      </Reference>
      <Reference refNo="131">
        <RefAuthor>Baba T</RefAuthor>
        <RefAuthor>Yamamoto S</RefAuthor>
        <RefAuthor>Kimoto R</RefAuthor>
        <RefAuthor>Oshitari T</RefAuthor>
        <RefAuthor>Sato E</RefAuthor>
        <RefTitle>Reduction of thickness of ganglion cell complex after internal limiting membrane peeling during vitrectomy for idiopathic macular hole</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>1173-80</RefPage>
        <RefTotal>Baba T, Yamamoto S, Kimoto R, Oshitari T, Sato E. Reduction of thickness of ganglion cell complex after internal limiting membrane peeling during vitrectomy for idiopathic macular hole. Eye (Lond). 2012 Sep;26(9):1173-80. DOI: 10.1038&#47;eye.2012.170</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;eye.2012.170</RefLink>
      </Reference>
      <Reference refNo="132">
        <RefAuthor>Baba T</RefAuthor>
        <RefAuthor>Hagiwara A</RefAuthor>
        <RefAuthor>Sato E</RefAuthor>
        <RefAuthor>Arai M</RefAuthor>
        <RefAuthor>Oshitari T</RefAuthor>
        <RefAuthor>Yamamoto S</RefAuthor>
        <RefTitle>Comparison of vitrectomy with brilliant blue G or indocyanine green on retinal microstructure and function of eyes with macular hole</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2609-15</RefPage>
        <RefTotal>Baba T, Hagiwara A, Sato E, Arai M, Oshitari T, Yamamoto S. Comparison of vitrectomy with brilliant blue G or indocyanine green on retinal microstructure and function of eyes with macular hole. Ophthalmology. 2012 Dec;119(12):2609-15. DOI: 10.1016&#47;j.ophtha.2012.06.048</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2012.06.048</RefLink>
      </Reference>
      <Reference refNo="133">
        <RefAuthor>Sabater AL</RefAuthor>
        <RefAuthor>Vel&#225;zquez-Villoria &#193;</RefAuthor>
        <RefAuthor>Zapata MA</RefAuthor>
        <RefAuthor>Figueroa MS</RefAuthor>
        <RefAuthor>Su&#225;rez-Leoz M</RefAuthor>
        <RefAuthor>Arrevola L</RefAuthor>
        <RefAuthor>Teijeiro M&#193;</RefAuthor>
        <RefAuthor>Garc&#237;a-Layana A</RefAuthor>
        <RefTitle>Evaluation of macular retinal ganglion cell-inner plexiform layer thickness after vitrectomy with internal limiting membrane peeling for idiopathic macular holes</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Biomed Res Int</RefJournal>
        <RefPage>458631</RefPage>
        <RefTotal>Sabater AL, Vel&#225;zquez-Villoria &#193;, Zapata MA, Figueroa MS, Su&#225;rez-Leoz M, Arrevola L, Teijeiro M&#193;, Garc&#237;a-Layana A. Evaluation of macular retinal ganglion cell-inner plexiform layer thickness after vitrectomy with internal limiting membrane peeling for idiopathic macular holes. Biomed Res Int. 2014;2014:458631. DOI: 10.1155&#47;2014&#47;458631</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2014&#47;458631</RefLink>
      </Reference>
      <Reference refNo="134">
        <RefAuthor>Modi A</RefAuthor>
        <RefAuthor>Giridhar A</RefAuthor>
        <RefAuthor>Gopalakrishnan M</RefAuthor>
        <RefTitle>Spectral domain optical coherence tomography-based microstructural analysis of retinal architecture post internal limiting membrane peeling for surgery of idiopathic macular hole repair</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>291-8</RefPage>
        <RefTotal>Modi A, Giridhar A, Gopalakrishnan M. Spectral domain optical coherence tomography-based microstructural analysis of retinal architecture post internal limiting membrane peeling for surgery of idiopathic macular hole repair. Retina. 2017 Feb;37(2):291-8. DOI: 10.1097&#47;IAE.0000000000001129</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000001129</RefLink>
      </Reference>
      <Reference refNo="135">
        <RefAuthor>Faria MY</RefAuthor>
        <RefAuthor>Ferreira NP</RefAuthor>
        <RefAuthor>Crist&#243;vao DM</RefAuthor>
        <RefAuthor>Mano S</RefAuthor>
        <RefAuthor>Sousa DC</RefAuthor>
        <RefAuthor>Monteiro-Grillo M</RefAuthor>
        <RefTitle>Tomographic Structural Changes of Retinal Layers after Internal Limiting Membrane Peeling for Macular Hole Surgery</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Ophthalmic Res</RefJournal>
        <RefPage>24-9</RefPage>
        <RefTotal>Faria MY, Ferreira NP, Crist&#243;vao DM, Mano S, Sousa DC, Monteiro-Grillo M. Tomographic Structural Changes of Retinal Layers after Internal Limiting Membrane Peeling for Macular Hole Surgery. Ophthalmic Res. 2018;59(1):24-9. DOI: 10.1159&#47;000480243</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1159&#47;000480243</RefLink>
      </Reference>
      <Reference refNo="136">
        <RefAuthor>Sevim MS</RefAuthor>
        <RefAuthor>Sanisoglu H</RefAuthor>
        <RefTitle>Analysis of retinal ganglion cell complex thickness after Brilliant Blue-assisted vitrectomy for idiopathic macular holes</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Curr Eye Res</RefJournal>
        <RefPage>180-4</RefPage>
        <RefTotal>Sevim MS, Sanisoglu H. Analysis of retinal ganglion cell complex thickness after Brilliant Blue-assisted vitrectomy for idiopathic macular holes. Curr Eye Res. 2013 Jan;38(1):180-4. DOI: 10.3109&#47;02713683.2012.738845</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3109&#47;02713683.2012.738845</RefLink>
      </Reference>
      <Reference refNo="137">
        <RefAuthor>Faria MY</RefAuthor>
        <RefAuthor>Ferreira NP</RefAuthor>
        <RefAuthor>Mano S</RefAuthor>
        <RefAuthor>Crist&#243;vao DM</RefAuthor>
        <RefAuthor>Sousa DC</RefAuthor>
        <RefAuthor>Monteiro-Grillo ME</RefAuthor>
        <RefTitle>Internal retinal layer thickness and macular migration after internal limiting membrane peeling in macular hole surgery</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Eur J Ophthalmol</RefJournal>
        <RefPage>311-6</RefPage>
        <RefTotal>Faria MY, Ferreira NP, Mano S, Crist&#243;vao DM, Sousa DC, Monteiro-Grillo ME. Internal retinal layer thickness and macular migration after internal limiting membrane peeling in macular hole surgery. Eur J Ophthalmol. 2018 May;28(3):311-6. DOI: 10.5301&#47;ejo.5001066</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.5301&#47;ejo.5001066</RefLink>
      </Reference>
      <Reference refNo="138">
        <RefAuthor>Kawano K</RefAuthor>
        <RefAuthor>Ito Y</RefAuthor>
        <RefAuthor>Kondo M</RefAuthor>
        <RefAuthor>Ishikawa K</RefAuthor>
        <RefAuthor>Kachi S</RefAuthor>
        <RefAuthor>Ueno S</RefAuthor>
        <RefAuthor>Iguchi Y</RefAuthor>
        <RefAuthor>Terasaki H</RefAuthor>
        <RefTitle>Displacement of foveal area toward optic disc after macular hole surgery with internal limiting membrane peeling</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Eye (Lond)</RefJournal>
        <RefPage>871-7</RefPage>
        <RefTotal>Kawano K, Ito Y, Kondo M, Ishikawa K, Kachi S, Ueno S, Iguchi Y, Terasaki H. Displacement of foveal area toward optic disc after macular hole surgery with internal limiting membrane peeling. Eye (Lond). 2013 Jul;27(7):871-7. DOI: 10.1038&#47;eye.2013.99</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;eye.2013.99</RefLink>
      </Reference>
      <Reference refNo="139">
        <RefAuthor>Ishida M</RefAuthor>
        <RefAuthor>Ichikawa Y</RefAuthor>
        <RefAuthor>Higashida R</RefAuthor>
        <RefAuthor>Tsutsumi Y</RefAuthor>
        <RefAuthor>Ishikawa A</RefAuthor>
        <RefAuthor>Imamura Y</RefAuthor>
        <RefTitle>Retinal displacement toward optic disc after internal limiting membrane peeling for idiopathic macular hole</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>971-7</RefPage>
        <RefTotal>Ishida M, Ichikawa Y, Higashida R, Tsutsumi Y, Ishikawa A, Imamura Y. Retinal displacement toward optic disc after internal limiting membrane peeling for idiopathic macular hole. Am J Ophthalmol. 2014 May;157(5):971-7. DOI: 10.1016&#47;j.ajo.2014.01.026</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2014.01.026</RefLink>
      </Reference>
      <Reference refNo="140">
        <RefAuthor>Ohta K</RefAuthor>
        <RefAuthor>Sato A</RefAuthor>
        <RefAuthor>Senda N</RefAuthor>
        <RefAuthor>Fukui E</RefAuthor>
        <RefTitle>Displacement of fovea toward optic disk after macular hole surgery with internal limiting membrane peeling</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Int Med Case Rep J</RefJournal>
        <RefPage>345-8</RefPage>
        <RefTotal>Ohta K, Sato A, Senda N, Fukui E. Displacement of fovea toward optic disk after macular hole surgery with internal limiting membrane peeling. Int Med Case Rep J. 2017;10:345-8. DOI: 10.2147&#47;IMCRJ.S148712</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;IMCRJ.S148712</RefLink>
      </Reference>
      <Reference refNo="141">
        <RefAuthor>Sun ZC</RefAuthor>
        <RefAuthor>Wang M</RefAuthor>
        <RefAuthor>Fan JW</RefAuthor>
        <RefAuthor>Xu GZ</RefAuthor>
        <RefTitle>Retinal displacement after closure of idiopathic macular hole</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Asian Pac J Trop Med</RefJournal>
        <RefPage>155-61</RefPage>
        <RefTotal>Sun ZC, Wang M, Fan JW, Xu GZ. Retinal displacement after closure of idiopathic macular hole. Asian Pac J Trop Med. 2018;11(2):155-61.</RefTotal>
      </Reference>
      <Reference refNo="142">
        <RefAuthor>Yoshikawa M</RefAuthor>
        <RefAuthor>Murakami T</RefAuthor>
        <RefAuthor>Nishijima K</RefAuthor>
        <RefAuthor>Uji A</RefAuthor>
        <RefAuthor>Ogino K</RefAuthor>
        <RefAuthor>Horii T</RefAuthor>
        <RefAuthor>Yoshimura N</RefAuthor>
        <RefTitle>Macular migration toward the optic disc after inner limiting membrane peeling for diabetic macular edema</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>629-35</RefPage>
        <RefTotal>Yoshikawa M, Murakami T, Nishijima K, Uji A, Ogino K, Horii T, Yoshimura N. Macular migration toward the optic disc after inner limiting membrane peeling for diabetic macular edema. Invest Ophthalmol Vis Sci. 2013 Jan;54(1):629-35. DOI: 10.1167&#47;iovs.12-10907</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.12-10907</RefLink>
      </Reference>
      <Reference refNo="143">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Schumann R</RefAuthor>
        <RefAuthor>Reiniger I</RefAuthor>
        <RefAuthor>Rohleder M</RefAuthor>
        <RefAuthor>Priglinger SG</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefTitle>Evaluation of the internal limiting membrane after conventional peeling during macular hole surgery</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>21-4</RefPage>
        <RefTotal>Haritoglou C, Schumann R, Reiniger I, Rohleder M, Priglinger SG, Kampik A, Gandorfer A. Evaluation of the internal limiting membrane after conventional peeling during macular hole surgery. Retina. 2006 Jan;26(1):21-4. DOI: 10.1097&#47;00006982-200601000-00004</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;00006982-200601000-00004</RefLink>
      </Reference>
      <Reference refNo="144">
        <RefAuthor>Haritoglou C</RefAuthor>
        <RefAuthor>Gass CA</RefAuthor>
        <RefAuthor>Schaumberger M</RefAuthor>
        <RefAuthor>Ehrt O</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefTitle>Macular changes after peeling of the internal limiting membrane in macular hole surgery</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>363-8</RefPage>
        <RefTotal>Haritoglou C, Gass CA, Schaumberger M, Ehrt O, Gandorfer A, Kampik A. Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol. 2001 Sep;132(3):363-8. DOI: 10.1016&#47;s0002-9394(01)01093-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;s0002-9394(01)01093-5</RefLink>
      </Reference>
      <Reference refNo="145">
        <RefAuthor>Tadayoni R</RefAuthor>
        <RefAuthor>Svorenova I</RefAuthor>
        <RefAuthor>Erginay A</RefAuthor>
        <RefAuthor>Gaudric A</RefAuthor>
        <RefAuthor>Massin P</RefAuthor>
        <RefTitle>Decreased retinal sensitivity after internal limiting membrane peeling for macular hole surgery</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1513-6</RefPage>
        <RefTotal>Tadayoni R, Svorenova I, Erginay A, Gaudric A, Massin P. Decreased retinal sensitivity after internal limiting membrane peeling for macular hole surgery. Br J Ophthalmol. 2012 Dec;96(12):1513-6. DOI: 10.1136&#47;bjophthalmol-2012-302035</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjophthalmol-2012-302035</RefLink>
      </Reference>
      <Reference refNo="146">
        <RefAuthor>Imai H</RefAuthor>
        <RefAuthor>Ohta K</RefAuthor>
        <RefTitle>Microperimetric determination of retinal sensitivity in areas of dissociated optic nerve fiber layer following internal limiting membrane peeling</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Jpn J Ophthalmol</RefJournal>
        <RefPage>435-40</RefPage>
        <RefTotal>Imai H, Ohta K. Microperimetric determination of retinal sensitivity in areas of dissociated optic nerve fiber layer following internal limiting membrane peeling. Jpn J Ophthalmol. 2010 Sep;54(5):435-40. DOI: 10.1007&#47;s10384-010-0839-4</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s10384-010-0839-4</RefLink>
      </Reference>
      <Reference refNo="147">
        <RefAuthor>Qi Y</RefAuthor>
        <RefAuthor>Wang Z</RefAuthor>
        <RefAuthor>Li SM</RefAuthor>
        <RefAuthor>You Q</RefAuthor>
        <RefAuthor>Liang X</RefAuthor>
        <RefAuthor>Yu Y</RefAuthor>
        <RefAuthor>Liu W</RefAuthor>
        <RefTitle>Effect of internal limiting membrane peeling on normal retinal function evaluated by microperimetry-3</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>BMC Ophthalmol</RefJournal>
        <RefPage>140</RefPage>
        <RefTotal>Qi Y, Wang Z, Li SM, You Q, Liang X, Yu Y, Liu W. Effect of internal limiting membrane peeling on normal retinal function evaluated by microperimetry-3. BMC Ophthalmol. 2020 Apr;20(1):140. DOI: 10.1186&#47;s12886-020-01383-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12886-020-01383-3</RefLink>
      </Reference>
      <Reference refNo="148">
        <RefAuthor>Cappello E</RefAuthor>
        <RefAuthor>Virgili G</RefAuthor>
        <RefAuthor>Tollot L</RefAuthor>
        <RefAuthor>Del Borrello M</RefAuthor>
        <RefAuthor>Menchini U</RefAuthor>
        <RefAuthor>Zemella M</RefAuthor>
        <RefTitle>Reading ability and retinal sensitivity after surgery for macular hole and macular pucker</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1111-8</RefPage>
        <RefTotal>Cappello E, Virgili G, Tollot L, Del Borrello M, Menchini U, Zemella M. Reading ability and retinal sensitivity after surgery for macular hole and macular pucker. Retina. 2009 Sep;29(8):1111-8. DOI: 10.1097&#47;IAE.0b013e3181a3b832</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0b013e3181a3b832</RefLink>
      </Reference>
      <Reference refNo="149">
        <RefAuthor>Michalewska Z</RefAuthor>
        <RefAuthor>Michalewski J</RefAuthor>
        <RefAuthor>Dulczewska-Cichecka K</RefAuthor>
        <RefAuthor>Adelman RA</RefAuthor>
        <RefAuthor>Nawrocki J</RefAuthor>
        <RefTitle>Temporal Inverted Internal Limiting Membrane Flap Technique versus Classic Inverted Internal Limiting Membrane Flap Technique: A Comparative Study</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1844-50</RefPage>
        <RefTotal>Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J. Temporal Inverted Internal Limiting Membrane Flap Technique versus Classic Inverted Internal Limiting Membrane Flap Technique: A Comparative Study. Retina. 2015 Sep;35(9):1844-50. DOI: 10.1097&#47;IAE.0000000000000555</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000555</RefLink>
      </Reference>
      <Reference refNo="150">
        <RefAuthor>Takai Y</RefAuthor>
        <RefAuthor>Tanito M</RefAuthor>
        <RefAuthor>Sugihara K</RefAuthor>
        <RefAuthor>Ohira A</RefAuthor>
        <RefTitle>The Role of Single-Layered Flap in Temporal Inverted Internal Limiting Membrane Flap Technique for Macular Holes: Pros and Cons</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>J Ophthalmol</RefJournal>
        <RefPage>5737083</RefPage>
        <RefTotal>Takai Y, Tanito M, Sugihara K, Ohira A. The Role of Single-Layered Flap in Temporal Inverted Internal Limiting Membrane Flap Technique for Macular Holes: Pros and Cons. J Ophthalmol. 2019;2019:5737083. DOI: 10.1155&#47;2019&#47;5737083</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2019&#47;5737083</RefLink>
      </Reference>
      <Reference refNo="151">
        <RefAuthor>Takai Y</RefAuthor>
        <RefAuthor>Tanito M</RefAuthor>
        <RefAuthor>Sugihara K</RefAuthor>
        <RefAuthor>Kodama T</RefAuthor>
        <RefAuthor>Ohira A</RefAuthor>
        <RefTitle>Temporal inverted internal limiting membrane flap technique for a macular hole patient unable to maintain postoperative prone positioning</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Retin Cases Brief Rep</RefJournal>
        <RefPage>323-6</RefPage>
        <RefTotal>Takai Y, Tanito M, Sugihara K, Kodama T, Ohira A. Temporal inverted internal limiting membrane flap technique for a macular hole patient unable to maintain postoperative prone positioning. Retin Cases Brief Rep. 2016;10(4):323-6. DOI: 10.1097&#47;ICB.0000000000000258</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;ICB.0000000000000258</RefLink>
      </Reference>
      <Reference refNo="152">
        <RefAuthor>Kumari A</RefAuthor>
        <RefAuthor>Agarwal L</RefAuthor>
        <RefAuthor>Agrawal N</RefAuthor>
        <RefAuthor>Sahu S</RefAuthor>
        <RefAuthor>Prasad I</RefAuthor>
        <RefAuthor>Pradhan D</RefAuthor>
        <RefTitle>Inverted temporal internal limiting membrane flap technique for chronic large traumatic macular hole</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>GMS Ophthalmol Cases</RefJournal>
        <RefArticleNo>Doc27</RefArticleNo>
        <RefTotal>Kumari A, Agarwal L, Agrawal N, Sahu S, Prasad I, Pradhan D. Inverted temporal internal limiting membrane flap technique for chronic large traumatic macular hole. GMS Ophthalmol Cases. 2020 May;10:Doc27. DOI: 10.3205&#47;oc000154</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3205&#47;oc000154</RefLink>
      </Reference>
      <Reference refNo="153">
        <RefAuthor>Shiono A</RefAuthor>
        <RefAuthor>Kogo J</RefAuthor>
        <RefAuthor>Sasaki H</RefAuthor>
        <RefAuthor>Yomoda R</RefAuthor>
        <RefAuthor>Jujo T</RefAuthor>
        <RefAuthor>Tokuda N</RefAuthor>
        <RefAuthor>Kitaoka Y</RefAuthor>
        <RefAuthor>Takagi H</RefAuthor>
        <RefTitle>Hemi-temporal internal limiting membrane peeling is as effective and safe as conventional full peeling for macular hole surgery</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1779-85</RefPage>
        <RefTotal>Shiono A, Kogo J, Sasaki H, Yomoda R, Jujo T, Tokuda N, Kitaoka Y, Takagi H. Hemi-temporal internal limiting membrane peeling is as effective and safe as conventional full peeling for macular hole surgery. Retina. 2019 Sep;39(9):1779-85. DOI: 10.1097&#47;IAE.0000000000002215</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000002215</RefLink>
      </Reference>
      <Reference refNo="154">
        <RefAuthor>Mahajan VB</RefAuthor>
        <RefAuthor>Chin EK</RefAuthor>
        <RefAuthor>Tarantola RM</RefAuthor>
        <RefAuthor>Almeida DR</RefAuthor>
        <RefAuthor>Somani R</RefAuthor>
        <RefAuthor>Boldt HC</RefAuthor>
        <RefAuthor>Folk JC</RefAuthor>
        <RefAuthor>Gehrs KM</RefAuthor>
        <RefAuthor>Russell SR</RefAuthor>
        <RefTitle>Macular Hole Closure With Internal Limiting Membrane Abrasion Technique</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>JAMA Ophthalmol</RefJournal>
        <RefPage>635-41</RefPage>
        <RefTotal>Mahajan VB, Chin EK, Tarantola RM, Almeida DR, Somani R, Boldt HC, Folk JC, Gehrs KM, Russell SR. Macular Hole Closure With Internal Limiting Membrane Abrasion Technique. JAMA Ophthalmol. 2015 Jun;133(6):635-41. DOI: 10.1001&#47;jamaophthalmol.2015.204</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;jamaophthalmol.2015.204</RefLink>
      </Reference>
      <Reference refNo="155">
        <RefAuthor>Almeida DR</RefAuthor>
        <RefAuthor>Chin EK</RefAuthor>
        <RefAuthor>Tarantola RM</RefAuthor>
        <RefAuthor>Folk JC</RefAuthor>
        <RefAuthor>Boldt HC</RefAuthor>
        <RefAuthor>Skeie JM</RefAuthor>
        <RefAuthor>Mullins RF</RefAuthor>
        <RefAuthor>Russell SR</RefAuthor>
        <RefAuthor>Mahajan VB</RefAuthor>
        <RefTitle>Effect of internal limiting membrane abrasion on retinal tissues in macular holes</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
        <RefPage>2783-9</RefPage>
        <RefTotal>Almeida DR, Chin EK, Tarantola RM, Folk JC, Boldt HC, Skeie JM, Mullins RF, Russell SR, Mahajan VB. Effect of internal limiting membrane abrasion on retinal tissues in macular holes. Invest Ophthalmol Vis Sci. 2015 May;56(5):2783-9. DOI: 10.1167&#47;iovs.14-16355</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1167&#47;iovs.14-16355</RefLink>
      </Reference>
      <Reference refNo="156">
        <RefAuthor>Dugel PU</RefAuthor>
        <RefAuthor>Tolentino M</RefAuthor>
        <RefAuthor>Feiner L</RefAuthor>
        <RefAuthor>Kozma P</RefAuthor>
        <RefAuthor>Leroy A</RefAuthor>
        <RefTitle>Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>2232-47</RefPage>
        <RefTotal>Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A. Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial. Ophthalmology. 2016 Oct;123(10):2232-47. DOI: 10.1016&#47;j.ophtha.2016.06.043</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2016.06.043</RefLink>
      </Reference>
      <Reference refNo="157">
        <RefAuthor>Stalmans P</RefAuthor>
        <RefAuthor>Benz MS</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefAuthor>Girach A</RefAuthor>
        <RefAuthor>Pakola S</RefAuthor>
        <RefAuthor>Haller JA</RefAuthor>
        <RefAuthor> MIVI-TRUST Study Group</RefAuthor>
        <RefTitle>Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>N Engl J Med</RefJournal>
        <RefPage>606-15</RefPage>
        <RefTotal>Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA; MIVI-TRUST Study Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012 Aug;367(7):606-15. DOI: 10.1056&#47;NEJMoa1110823</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1056&#47;NEJMoa1110823</RefLink>
      </Reference>
      <Reference refNo="158">
        <RefAuthor>Haller JA</RefAuthor>
        <RefAuthor>Stalmans P</RefAuthor>
        <RefAuthor>Benz MS</RefAuthor>
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Pakola SJ</RefAuthor>
        <RefAuthor>Girach A</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefAuthor>Jaffe GJ</RefAuthor>
        <RefAuthor>Toth CA</RefAuthor>
        <RefAuthor> MIVI-TRUST Study Group</RefAuthor>
        <RefTitle>Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Ophthalmology</RefJournal>
        <RefPage>117-22</RefPage>
        <RefTotal>Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A, Kampik A, Jaffe GJ, Toth CA; MIVI-TRUST Study Group. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology. 2015 Jan;122(1):117-22. DOI: 10.1016&#47;j.ophtha.2014.07.045</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ophtha.2014.07.045</RefLink>
      </Reference>
      <Reference refNo="159">
        <RefAuthor>Gandorfer A</RefAuthor>
        <RefAuthor>Benz MS</RefAuthor>
        <RefAuthor>Haller JA</RefAuthor>
        <RefAuthor>Stalmans P</RefAuthor>
        <RefAuthor>Pakola SJ</RefAuthor>
        <RefAuthor>Girach A</RefAuthor>
        <RefAuthor>Kampik A</RefAuthor>
        <RefAuthor>Toth CA</RefAuthor>
        <RefAuthor>Jaffe GJ</RefAuthor>
        <RefAuthor> MIVI-TRUST Study Group</RefAuthor>
        <RefTitle>Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion&#47;vitreomacular traction, including when associated with macular hole</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1151-7</RefPage>
        <RefTotal>Gandorfer A, Benz MS, Haller JA, Stalmans P, Pakola SJ, Girach A, Kampik A, Toth CA, Jaffe GJ; MIVI-TRUST Study Group. Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion&#47;vitreomacular traction, including when associated with macular hole. Retina. 2015 Jun;35(6):1151-7. DOI: 10.1097&#47;IAE.0000000000000508</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000508</RefLink>
      </Reference>
      <Reference refNo="160">
        <RefAuthor>Dugel PU</RefAuthor>
        <RefAuthor>Regillo C</RefAuthor>
        <RefAuthor>Eliott D</RefAuthor>
        <RefTitle>Characterization of Anatomic and Visual Function Outcomes in Patients With Full-Thickness Macular Hole in Ocriplasmin Phase 3 Trials</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Am J Ophthalmol</RefJournal>
        <RefPage>94-9</RefPage>
        <RefTotal>Dugel PU, Regillo C, Eliott D. Characterization of Anatomic and Visual Function Outcomes in Patients With Full-Thickness Macular Hole in Ocriplasmin Phase 3 Trials. Am J Ophthalmol. 2015 Jul;160(1):94-9.e1. DOI: 10.1016&#47;j.ajo.2015.03.017</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajo.2015.03.017</RefLink>
      </Reference>
      <Reference refNo="161">
        <RefAuthor>Greven MA</RefAuthor>
        <RefAuthor>Garg S</RefAuthor>
        <RefAuthor>Chiu B</RefAuthor>
        <RefAuthor>Shah SP</RefAuthor>
        <RefAuthor>Wolfe J</RefAuthor>
        <RefAuthor>Fine HF</RefAuthor>
        <RefAuthor>Roth DB</RefAuthor>
        <RefAuthor>Robinson J</RefAuthor>
        <RefAuthor>Mong J</RefAuthor>
        <RefAuthor>Hsu J</RefAuthor>
        <RefAuthor>Regillo C</RefAuthor>
        <RefAuthor>Ho A</RefAuthor>
        <RefAuthor>Haller JA</RefAuthor>
        <RefTitle>Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Br J Ophthalmol</RefJournal>
        <RefPage>1211-5</RefPage>
        <RefTotal>Greven MA, Garg S, Chiu B, Shah SP, Wolfe J, Fine HF, Roth DB, Robinson J, Mong J, Hsu J, Regillo C, Ho A, Haller JA. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study. Br J Ophthalmol. 2016 Sep;100(9):1211-5. DOI: 10.1136&#47;bjophthalmol-2015-307701</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;bjophthalmol-2015-307701</RefLink>
      </Reference>
      <Reference refNo="162">
        <RefAuthor>Schumann RG</RefAuthor>
        <RefAuthor>Wolf A</RefAuthor>
        <RefAuthor>Hoerauf H</RefAuthor>
        <RefAuthor>Lommatzsch A</RefAuthor>
        <RefAuthor>Maier M</RefAuthor>
        <RefAuthor>Wachtlin J</RefAuthor>
        <RefAuthor>Koss MJ</RefAuthor>
        <RefAuthor>Kreutzer T</RefAuthor>
        <RefAuthor>Bertelmann T</RefAuthor>
        <RefAuthor>Kazerounian S</RefAuthor>
        <RefAuthor>Mennel S</RefAuthor>
        <RefAuthor>Priglinger SG</RefAuthor>
        <RefTitle>Vitrectomy for Persistent Macular Holes Following Ocriplasmin Injection: A Comparative Multicenter Study</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>2295-303</RefPage>
        <RefTotal>Schumann RG, Wolf A, Hoerauf H, Lommatzsch A, Maier M, Wachtlin J, Koss MJ, Kreutzer T, Bertelmann T, Kazerounian S, Mennel S, Priglinger SG. Vitrectomy for Persistent Macular Holes Following Ocriplasmin Injection: A Comparative Multicenter Study. Retina. 2017 Dec;37(12):2295-303. DOI: 10.1097&#47;IAE.0000000000001473</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000001473</RefLink>
      </Reference>
      <Reference refNo="163">
        <RefAuthor>Prospero Ponce CM</RefAuthor>
        <RefAuthor>Stevenson W</RefAuthor>
        <RefAuthor>Gelman R</RefAuthor>
        <RefAuthor>Agarwal DR</RefAuthor>
        <RefAuthor>Christoforidis JB</RefAuthor>
        <RefTitle>Ocriplasmin: who is the best candidate&#63;</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Clin Ophthalmol</RefJournal>
        <RefPage>485-95</RefPage>
        <RefTotal>Prospero Ponce CM, Stevenson W, Gelman R, Agarwal DR, Christoforidis JB. Ocriplasmin: who is the best candidate&#63; Clin Ophthalmol. 2016;10:485-95. DOI: 10.2147&#47;OPTH.S97947</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;OPTH.S97947</RefLink>
      </Reference>
      <Reference refNo="164">
        <RefAuthor>Hahn P</RefAuthor>
        <RefAuthor>Chung MM</RefAuthor>
        <RefAuthor>Flynn HW Jr</RefAuthor>
        <RefAuthor>Huang SS</RefAuthor>
        <RefAuthor>Kim JE</RefAuthor>
        <RefAuthor>Mahmoud TH</RefAuthor>
        <RefAuthor>Sadda SR</RefAuthor>
        <RefAuthor>Dugel PU</RefAuthor>
        <RefTitle>Safety Profile of Ocriplasmin for Symptomatic Vitreomacular Adhesion: A Comprehensive Analysis of Premarketing and Postmarketing Experiences</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Retina</RefJournal>
        <RefPage>1128-34</RefPage>
        <RefTotal>Hahn P, Chung MM, Flynn HW Jr, Huang SS, Kim JE, Mahmoud TH, Sadda SR, Dugel PU. Safety Profile of Ocriplasmin for Symptomatic Vitreomacular Adhesion: A Comprehensive Analysis of Premarketing and Postmarketing Experiences. Retina. 2015 Jun;35(6):1128-34. DOI: 10.1097&#47;IAE.0000000000000519</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;IAE.0000000000000519</RefLink>
      </Reference>
      <Reference refNo="165">
        <RefAuthor>Tibbetts MD</RefAuthor>
        <RefAuthor>Reichel E</RefAuthor>
        <RefAuthor>Witkin AJ</RefAuthor>
        <RefTitle>Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>JAMA Ophthalmol</RefJournal>
        <RefPage>487-90</RefPage>
        <RefTotal>Tibbetts MD, Reichel E, Witkin AJ. Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA Ophthalmol. 2014 Apr;132(4):487-90. DOI: 10.1001&#47;jamaophthalmol.2013.8258</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;jamaophthalmol.2013.8258</RefLink>
      </Reference>
      <Reference refNo="166">
        <RefAuthor>Fahim AT</RefAuthor>
        <RefAuthor>Khan NW</RefAuthor>
        <RefAuthor>Johnson MW</RefAuthor>
        <RefTitle>Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>JAMA Ophthalmol</RefJournal>
        <RefPage>484-6</RefPage>
        <RefTotal>Fahim AT, Khan NW, Johnson MW. Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection. JAMA Ophthalmol. 2014 Apr;132(4):484-6. DOI: 10.1001&#47;jamaophthalmol.2013.8142</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;jamaophthalmol.2013.8142</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>